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Abstract
Human papillomavirus (HPV) is the most common sexually transmitted infection (STI) in the
US and causes several cancers. HPV vaccines can protect individuals against multiple HPV
strains that can cause certain cancers. Despite the benefits, 51% of college women have received
the HPV vaccine. The purpose of this study was to better understand why women choose to get
the HPV vaccine and others do not. An emailed link was sent to 8,889 EMU female
undergraduate students. Chi-Square Tests for Independence were used to determine relationships
between variables. Data from 1,126 female undergraduates ranging in age from 18 to 26 were
analyzed. Participants‟ intention to receive HPV vaccination was significantly related to
participants‟ perceived susceptibility, severity, benefits and barriers. Participants with intention to
get the HPV vaccine were in stable relationships, use condoms consistently, and have a friend,
parent, or doctor who advocates for the HPV vaccine.
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Chapter I: Introduction

According to the Centers for Disease Control and Prevention (CDC; 2014), HPV is the most
common sexually transmitted infection (STI) in the US. The majority of individuals who are
sexually active will be exposed to HPV at some point in their lives. There are 14 million new
infections diagnosed each year (CDC, 2014). Based on data from the National Center for
Immunization and Respiratory Diseases (2014), about 79 million people were infected (new and
current cases) with HPV in the United States during any given year.
Depending on the source, there are between 100 and 200 different strains of HPV. HPV is a
group of related viruses; each HPV in the group is assigned a number or type. Most types of
HPV cause warts on the skin while other types can be found only on the body‟s mucous
membranes. The types of HPV found on the mucous membranes are called genital HPV
(American Cancer Society, 2015). The moist surface layers of the vagina, anus, mouth, and
throat are mucous membranes where genital HPV is found.
Most strains of HPV do not cause symptoms or health problems. In most cases, individuals
with HPV do not know they are infected, never develop symptoms or health problems, and the
HPV goes away on its own (CDC, 2014). About 40 types of HPV are known to cause genital
warts or cause cellular changes that may develop into cancer (American Cancer Society, 2015).
These HPV strains can be transmitted to sexual partners during all types of sexual contact
including oral sex, anal sex, vaginal sex, and skin to skin contact (Dunne et al., 2007). In some
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cases, the virus can cause genital warts. Like other types of warts, the warts can be removed or
may go away on their own if left untreated or could grow in size and number (CDC, 2014). More
seriously, HPV can cause several types of cancer such as anal cancer, cervical cancer, vaginal
cancer, oropharyngeal cancer, penile cancer, and vulvar cancer (CDC, 2014). Data from the CDC
(2014) shows that in the United States, more than 11,000 women are diagnosed with cervical
cancer every year. Specific strains of HPV can be isolated as the etiologic agent in 99.7% of
cervical cancer cases (Dunne et al., 2007). The strains of HPV associated with cervical cancer
are considered to be “high risk strains” and differ from those that cause genital warts. Due to
how common HPV is, how easily it is transmitted between partners, and the potential
consequences of HPV infection, it is necessary to reduce the number of people infected with the
strains of HPV linked to genital warts and cervical cancer.
Since the majority of HPV infections do not show symptoms, diagnosis and prevention is
difficult. Vaccination is one of the most efficient methods to prevent and control numerous
infectious diseases including HPV. Three HPV vaccines were approved by the U.S. Food and
Drug Administration (FDA) to protect against the two high-risk HPV types (HPV-16 and
HPV-18; CDC, 2015). Gardasil®, the one used predominantly in the U.S., was licensed in 2006
and protects against two high-risk HPV types (HPV-16 and HPV-18) and two low-risk types
(HPV-6 and HPV-11) that cause genital warts (CDC, 2010). Another vaccine, Cervarix®, was
licensed in 2009 and protects against HPV-16 and HPV-18 only (CDC, 2010). Moreover, the
Advisory Committee on Immunization Practices (ACIP) recently recommended the 9-valent
HPV vaccine (9vHPV; Gardasil 9, Merck and Co., Inc.) as the newest HPV vaccine available
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(CDC, 2015). In addition to HPV-6, HPV-11, HPV-16, and HPV-18, the new 9-valent vaccine
also protects against HPV 31, 33, 45, 52, 58 (CDC, 2015). Approximately 10% of the
HPV-associated cancers are caused by HPV 31, 33, 45, 52, 58 (CDC, 2015).
In order to exploit the benefits of the HPV vaccine, the best recommendation is to apply the
HPV vaccine to adolescents and young women before they become sexually active (The Lancet
Infectious Diseases, 2006). The HPV vaccine provides a remarkable breakthrough in the
prevention of HPV related cancers, especially cervical cancer (Donadiki et al., 2014). CDC data
indicates that about 21,000 cancer cases related to HPV could be prevented each year by
individuals receiving the HPV vaccine (CDC, 2014). Of all vaccines used today, the HPV
vaccine has the second highest potential per-person impact on reducing mortality, preventing
15.1 per 1000 persons from death (Lee., 2014).
Despite the HPV vaccine‟s effectiveness in preventing HPV infection and reducing cancer
rates, the vaccination rate is still lower than desired. Vaccination rates for the recommended age
group of 9–26 year olds is 37% (CDC, 2012). Although the vaccination rate (51.1%) for female
college students is higher than the recommended age group, the vaccination rate is still
considered to be low by vaccination standards (American College Health Association, 2014).
Knowledge level about HPV, HPV--related cancers, and HPV vaccination is related to
decisions people make about receiving the HPV vaccination (Kessels et al., 2012). In research
studies about HPV vaccination, significant differences were found in vaccination rates based on
people‟s race (Niccolai, Mehta, & Hadler, 2011; Neubrand, R. Breitkopf, Rupp, D. Breitkopf, &
Rosenthal, 2009). One study found that White adolescents were significantly more likely to
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complete the HPV vaccinations series than African Americans or Hispanics (Niccolai et al.,
2011). In the group of people who complete the HPV vaccination, 65% are White while 12.9%
are Black and 15.2% are Hispanic. However, the other study found that Hispanics (38.8%) were
significantly less likely to complete the series than African Americans (48.6%; Neubrand et al.,
2009).

Theoretical Framework
The Health Belief Model (HBM) is a value-expectancy theory used to explain change and
maintenance of health-related behaviors (Janz, Champion, & Stretcher, 2002). The HBM
suggests that behavior is a function of the expectancies an individual has and how much value
they place on the expected outcome; people will choose behaviors that have the most expected
success and value. As one of the most commonly used theoretical frameworks to illustrate health
behaviors, the HBM (Becker, 1974) has played an important role in vaccine related behavior
change. According to the authority textbook on theory application in health education, the HBM
constructs have been examined in relationship to vaccine uptake in at least 15 separate studies
(Glanz, 2008). The Health Belief Model has six constructs including perceived susceptibility,
perceived severity, perceived benefits, perceived barriers, cues to action, and self-efficacy (Janz
et al., 2002). All six constructs were used in this study to help explain HPV vaccination intention.
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Purpose of the Study
The purpose of this study was to use the Health Belief Model to identify the main construct
items and factors that relate to whether or not an Eastern Michigan University female
undergraduate intends to receive the HPV vaccine.

Research Questions
1. Is there any relationship between participants‟ perceived susceptibility and their intentions to
receive the HPV vaccination?
Null Hypothesis: There is no relationship between participants‟ perceived susceptibility and
their intentions to receive the HPV vaccination.
Hypothesis: Participants who have more perceived susceptibility have more intention to
receive the HPV vaccination.
2. Is there any relationship between participants‟ perceived severity and their intentions to
receive the HPV vaccination?
Null Hypothesis: There is no relationship between participants‟ perceived severity and their
intentions to receive the HPV vaccination.
Hypothesis: Participants who have more perceived severity have more intention to receive
the HPV vaccination.
3. Is there any relationship between participants‟ perceived benefits and their intentions to
receive the HPV vaccination?
Null Hypothesis: There is no relationship between participants‟ perceived benefits and their
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intentions to receive the HPV vaccination.
Hypothesis: Participants who have more perceived benefits have more intention to receive
the HPV vaccination.
4. Is there any relationship between participants‟ perceived barriers and their intentions to
receive the HPV vaccination?
Null Hypothesis: There is no relationship between participants‟ perceived barriers and their
intentions to receive the HPV vaccination.
Hypothesis: Participants who have more perceived barriers have less intention to receive the
HPV vaccination.
5. Is there any relationship between participants‟ perceived cues to action and their intentions to
receive the HPV vaccination?
Null Hypothesis: There is no relationship between participants‟ perceived cues to action and
their intentions to receive the HPV vaccination.
Hypothesis: Participants who have more perceived cues to action have more intention to
receive the HPV vaccination.
6. Is there any relationship between participants‟ perceived self-efficacy and their intentions to
receive the HPV vaccination?
Null Hypothesis: There is no relationship between participants‟ perceived self-efficacy and
their intentions to receive the HPV vaccination.
Hypothesis: Participants who have more perceived self-efficacy have more intention to
receive the HPV vaccination.
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7. Is there any relationship between participants‟ race and their intentions to receive the HPV
vaccination?
Null Hypothesis: There is no relationship between participants‟ race and their intentions to
receive the HPV vaccination.
Hypothesis: Participants who are white have more intention to receive the HPV vaccination.
8. Is there any relationship between participants‟ grade point average and their intentions to
receive the HPV vaccination?
Null Hypothesis: There is no relationship between participants‟ grade point average and their
intention to receive the HPV vaccination.
Hypothesis: Participants who have higher grade point average have more intention to receive
the HPV vaccination.

Significance of Study
There are only a few studies focusing on the knowledge and attitude toward the HPV
vaccine in adolescents, young adults, and their parents in different countries. Many studies focus
on adolescent vaccination rates because the recommendation for HPV vaccine is for boys and
girls ages 11–12. However, the vaccination rate for college age women is 51.1%, which means
the traditional college age population can still benefit from vaccination efforts if they fall within
the recommended 9–26 age group. While some studies have used concepts from the HBM, the
HBM has only been applied in one Greek research study for college women regarding intentions
to get the HPV vaccine (Donadiki et al., 2014). They found that college students who had more
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perceived barriers and less perceived benefits were more likely to report being unvaccinated
(Donadiki et al., 2014). At the time of this study there were no published studies found using the
Health Belief Model (HBM) in the United States to address an individual‟ s intention of
receiving the HPV vaccination. This study provided information that could help in the
development of interventions focused on increasing the HPV vaccine rate.

Definition of Terms
1. Cervical cancer–Disease characterized by the abnormal growth of cells in the cervix, the
region of the uterus that joins the vagina (Encyclopedia Britannica Online, 2014).
2. Cues to action–Strategies to activate readiness (Glanz, 2008).
3. Genital warts–Genital warts are caused by the human papillomavirus. Some strains of genital
HPV can cause genital warts, while others can cause cancer. (Mayo Clinic, 2014).
4. Health Belief Model (HBM)–A theory to explain change and maintenance of health-related
behaviors and as a guiding framework for the health behavior interventions. Perceived
susceptibility, perceived severity, perceived benefits, perceived barriers, cues to action, and
self-efficacy are the six components of the HBM (Glanz, 2008).
5. High-risk human papillomavirus (HPV)–High-risk HPV types are detected in almost all
cervical cancers; approximately 70% of cervical cancers worldwide are due to types 16 and
18 (Bosch et al., 2008).
6. Human papillomavirus (HPV)–Any one of a class of viruses that cause tumors, including
warts, in humans. Certain strains infect the cervix and have been implicated as a cause of
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cervical cancer (Collins English Dictionary, 2003).
7. Low-risk human papillomavirus (HPV)–Such as HPV-6 or HPV-11, can cause (1) benign or
low-grade abnormalities of cervical cells, (2) anogenital warts, and (3) a disease of the
respiratory tract called recurrent respiratory papillomatosis (RRP) (Lacey, Lowndes, & Shah,
2006).
8. Perceived barriers–Belief about the tangible and psychological costs of the advised action
(Glanz, 2008).
9. Perceived benefits–Belief in efficacy of the advised action to reduce risk of seriousness of
impact (Glanz, 2008).
10. Perceived severity–Belief about how serious a condition and its sequelae are (Glanz, 2008).
11. Perceived susceptibility–Belief about the chances of experiencing a risk or getting condition
or disease (Glanz, 2008).
12. Self-efficacy–Confidence in one‟s ability to take action (Glanz, 2008).
13. Undergraduate student–a student in a university or college who has not received a first,
especially a bachelor's, degree.
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Chapter II: Review of literature

Human Papillomavirus
Human papillomavirus (HPV) is a common type of virus that can be found on human skin
and mucous membranes (Trottier, 2006). Depending on the source, there are 200 different types
of HPV identified currently (National Center for Immunization and Respiratory Diseases, 2015)
but only 40 types of HPV contaminate mucosal areas of the body, especially the genitals, anus,
mouth, and throat (Trottier, 2006). Data from the Centers for Disease Control and Prevention
(CDC; 2014) indicate that HPV infections are the most commonly diagnosed sexually
transmitted infection today. It is usually spread through vaginal or anal sex but can also be spread
through oral sex or by skin to skin contact (CDC, 2014). The majority of HPV strains do not
cause visible symptoms. However, some HPV strains, such as HPV-6 and HPV-11 can cause
benign lesions of the anogenital areas (de Villiers, Gunst, Stein, & Scherübl, 2004). In addition,
other common symptoms caused by HPV-6 and HPV-11 are genital warts and a large proportion
of low-grade squamous intraepithelial lesions of the cervix (Trottier, 2006).
While the HPV virus itself cannot be cured, there are ways to treat the symptoms caused by
HPV. Visible genital warts can be treated by topical medications or out-patient procedures like
cryotherapy using liquid nitrogen. In some cases when left untreated, genital warts will disappear
on their own (National Center for Immunization and Respiratory Diseases, 2015). Most cases of
HPV that resolve on their own are not associated with cancer development, it is the HPV that
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does not go away on its own that is associated with genital warts and cancer (CDC, 2015). The
HPV-related cancer treatment possibilities depend on multiple conditions, such as severity of the
symptoms, the individual‟s age, past medical history, and other test results (National Center for
Immunization and Respiratory Diseases, 2015).

Human Papillomavirus and Cancer
Strong epidemiologic and molecular evidence suggests that HPV contributes to cervical
cancer (Koutsky, 1997). Among all strains of HPV, strains 13–18 are considered to be
high-oncogenic risk types (Trottier, 2006). The types of HPV most commonly detected in
cancers are HPV-16 and HPV-18 (Koutsky, 1997). Research indicates that high-risk HPV
infections are the cause of almost all cases of cervical cancer in the world (Trottier, 2006). There
are 12,000 new cases of cervical cancer and over 4,000 deaths from cervical cancer annually in
the United States (Siegel, Ma, Zou, & Jemal, 2014). Moreover, the high-risk HPV infections are
a likely cause of a substantial proportion of other anogenital cancer such as anal cancer, cervical
cancer, vaginal cancer, oropharyngeal cancer, penile cancer, and vulvar cancer (Trottier, 2006).

Human Papillomavirus Vaccination
According to the U.S. Food and Drug Administration (FDA; 2015), there are three kinds of
HPV vaccinations licensed currently. Gardasil® is used primarily in the U.S, and it was licensed
in 2006. Gardasil® protects against two high-risk HPV types (HPV-16 and HPV-18) and two
low-risk types (HPV-6 and HPV-11; FDA, 2006). Gardasil® is also available for males (National
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Center for Immunization and Respiratory Diseases, 2015). Cervarix® is another vaccine and
only protects against HPV-16 and HPV-18 and was licensed in 2009 (FDA, 2006). Gardasil®
was studied in clinical trials with 29,000 females and males while Cervarix® trials included
more than 30,000 females (National Center for Immunization and Respiratory Diseases, 2015).
Moreover, the Advisory Committee on Immunization Practices (ACIP) recently recommended
9-valent HPV vaccine (9vHPV; Gardasil 9, Merck and Co., Inc.) as the newest HPV vaccine
(CDC, 2015). In addition to HPV-6, HPV-11, HPV-16, and HPV-18, the new 9-valent vaccine
also guards against HPV 31, 33, 45, 52, 58 (CDC, 2015). Besides the high-risk HPV types
HPV-16 and HPV-18, approximately 10% of the HPV-associated cancers are caused by HPV 31,
33, 45, 52, 58 (CDC, 2015).
The regular reactions of the vaccination are pain or redness in the arm where the shot is
given (National Center for Immunization and Respiratory Diseases, 2015). According to clinical
trials, at this point in time the HPV vaccine lasts more than 10 years without losing its
effectiveness (National Center for Immunization and Respiratory Diseases, 2015). HPV vaccines
are provided as a series of three shots over six months with the second shot being given one
month after the first and the final dose six months after the first dose. To receive the most
protection, the second and third doses should be taken during the recommended time frame of six
months. However, there is still protection from the vaccine if the follow-up doses are taken after
the six month time frame (National Center for Immunization and Respiratory Diseases, 2015).
The CDC and the American Academy of Pediatrics recommend both males and females be
vaccinated at ages 11–12 or by age 13 (National Center for Immunization and Respiratory
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Diseases, 2015). It is best to receive the vaccination before becoming sexually active because our
bodies may need time to develop an immune response before coming into contact with the virus
(National Center for Immunization and Respiratory Diseases, 2015).
There has been a 56% decrease in HPV infections since 2006 among young females in the
US, even with very low HPV vaccination rates (National Center for Immunization and
Respiratory Diseases, 2014). The CDC (2014) reports HPV vaccination coverage among
13–17-year-old adolescents from 2007 to 2013. The rates from 2006–2008 would most likely be
our 20–21-year-old college undergraduates now. About 25% of the girls received more than 1
dose and 5.9% finished all 3 doses in 2007. In 2008, 37% received more than one dose and 17.9%
finished all three doses. Although the vaccination rates increased through 2013, the 2013 rate for
those receiving all 3 doses is still extremely low at 37.6%. These data indicate the undergraduate
population is a very important target population for HPV vaccination. Because of low HPV
vaccination rates, experts suggest females up to age 26 and males up to age 21 could benefit
from receiving the HPV vaccine (National Center for Immunization and Respiratory Diseases,
2015).
Since the U.S. Food and Drug Administration (FDA) licensed the new vaccine for females to
prevent HPV in 2006, the HPV vaccine became an exceedingly popular topic in health education
and other health-related fields. However, from the CDC (2014) data, 15.5% of parents lack
knowledge and 14.7% of parents considered HPV vaccination unnecessary. Friedman and
Shepeard (2007) showed that the general public had a low level of HPV awareness and
knowledge about HPV and HPV vaccination which despite race, gender, and urban/rural
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locations studied.
Most recent studies have focused on the knowledge and attitude of adolescents, young adults,
and their parents towards HPV and HPV vaccination (Lee, Ho, Cheung, & Keung, 2014; Cohen
& Head, 2013; Constantine & Jerman, 2007; Donati et al., 2012; Friedman & Shepeard, 2007;
Kessels et al., 2012; Kessels et al., 2013; Manhart et al., 2011; Marek et al., 2011; Reiter et al.,
2009). In a Hong Kong study, adolescent girls reported that media was the main channel of
information about HPV and HPV vaccination. They received very little information from schools
or their parents. The educational gap was considered one of the reasons for the low HPV vaccine
uptake rate among adolescents and young adults (Lee et al., 2014). Concerns about effects on
adolescent sexual behavior, HPV vaccine concerns such as side effects, moral concerns about
their daughters‟ sexual behavior, and a denial of need were identified as the major reasons that
parents refused to vaccinate their daughters against HPV (Constantine & Jerman, 2007).
Researchers have also found that significant differences in HPV vaccination rates exist in
different races, ethnicities, and socioeconomic statuses (Niccolai, Mehta, & Hadler, 2011).
Caucasians were more likely to finish all three doses of HPV vaccination than were African
Americans or Hispanics (Neubrand, R. Breitkopf, Rupp, D. Breitkopf, & Rosenthal, 2009). In an
Australian research study, health insurance status, increasing age, childhood vaccine history,
HPV vaccine-related knowledge, healthcare utilization, and access to healthcare institutions were
considered as positively related to intentions for HPV vaccination (Kessels et al., 2012). People
with private insurance were more likely to finish the HPV vaccination series than those
participants with Medicaid/CHIP (Neubrand et al., 2009).
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Research on College Students
Data show the peak prevalence of genital HPV infection is in adults 18–28 years of age
which is during the college years (Koutsky, 1997). College students‟ sexual behaviors are
complex. According to the American College Health Association (ACHA; 2014), 25% of college
females have two or more sexual partners in one year. Only half of college females reported
using condoms when having vaginal intercourse within the past 30 days (ACHA, 2014). Only
4.3% of females have used condoms during oral sex within the past 30 days (ACHA, 2014).
Condom use may reduce risk of HPV transmission, but HPV may still be contracted through
skin-to-skin contact of areas not covered by a condom. Based on their reported behaviors,
college students should be considered an important population for HPV vaccination. Additionally,
college is a time that young adults start making their own vaccination decisions. In 2008, 31.8%
of college students reported receiving the vaccination against HPV (ACHA, 2008). According to
ACHA (2014), the current HPV vaccination rate for national undergraduates is 51.1%. The
vaccination rate increased nearly 20% during the last 7 years. However, the vaccination rate is
still too low.
Although one research study has been conducted on HPV vaccine rates and college students
(Krawczyk, Stephenson, Perez, Lau, & Rosberger, 2013), it was not conducted in the United
States and the participants in the research were male. The researchers found that males who
reported using condoms every time they had sex had a higher probability to make a decision to
get the HPV vaccine (Krawczyk et al., 2013). Student status, which means currently receiving
any level of education, had a positive effect on peoples‟ intention to receive the HPV vaccination
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(Manhart et al., 2011). Most college males had some awareness of HPV and the HPV vaccine but
low knowledge level about HPV and HPV vaccination overall (Krawczyk et al., 2013).
Perceived knowledge, what people think they know, and objective HPV vaccine knowledge,
what people actually know, were studied. Perceived knowledge was related to intention to get the
HPV vaccination (Krawczyk et al., 2013). Perceived HPV vaccine knowledge significantly
influenced the vaccination intentions of male students. While knowledge and attitude were
studied, the HBM was not used as a theoretical framework in the study (Krawczyk et al., 2013).

Application of Health Belief Model to HPV Vaccination
The Heath Belief Model (HBM) was developed by Hochbaum, Leventhal, Kegeles, and
Rosenstock in the 1950s (Janz, Champion, & Strecher, 2002). The model was first designed to
explain the failure of people to attend public health programs that prevent and detect disease
(Rosenstock, I. M. 1974). Currently the model guides health educators for designing
interventions to promote prevention. There are five key components of the HBM: perceived
susceptibility, perceived severity, perceived benefits, perceived barriers, and cues to action (Janz
et al., 2002). The self-efficacy construct was later added to the HBM by Bandura in 1977 (Janz et
al., 2002).
There was only one study that directly applied the HBM to HPV vaccination for college
female students. The research in Greece conducted with college students indicated that the
constructs, perceived barriers and perceived benefits, were related to HPV vaccination intention
(Donadiki et al., 2014). This research found that college students who had more perceived
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barriers and less perceived benefits were more likely to report being unvaccinated (Donadiki et
al., 2014).
Besides Donadiki‟s article, there is another research study in the United States that used the
HBM to assess parents‟ health belief and the vaccination rates of their daughters (Reiter, Brewer,
Gottlieb, McRee, & Smith, 2009). This research used three HBM constructs, cues to action (a
doctor's recommendation to get HPV vaccine), perceived susceptibility, and perceived barriers to
obtaining HPV vaccine. Parental beliefs did not differ between racial groups or urban/rural status
and were considered as having a significant correlation with HPV vaccination initiation (Reiter,
2009).
Brewer and Fazekas (2007) summarized 27 studies on HPV beliefs and HPV vaccine
acceptability among adolescents, young adults, and parents of adolescents in the United States
and concluded that the United States should highlight high vaccine efficiency, the high
possibility of HPV infection, and doctors' recommendations. They also recommended health
professionals address the barriers to HPV vaccine programs in the United States.
Although there were not many studies directly applying the HBM model in researching HPV
and HPV vaccination related behaviors, the studies that I did find were helpful in choosing my
theoretical framework.
Health Belief Model Constructs
Perceived susceptibility. Perceived susceptibility is the belief about the chances of
experiencing a risk or getting a condition or disease (Glanz, 2008). Perceived susceptibility of
HPV is the belief that you could get infected by HPV. An example of a susceptibility question for
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HPV is “How likely do you think it is that you will get HPV?” (Manhart et al., 2011, p. 5239). In
an Italian study, 59% of young female adults reported being worried about being infected by
HPV (Donati et al., 2012). Perceived susceptibility towards HPV played a higher role than
knowledge acquirement for vaccinated women because women who had no knowledge of HPV
still reported receiving the HPV vaccination (Cohen & Head, 2013). In a research study of young
adult women, intention to vaccinate was less common among people perceiving they had low
susceptibility to infection (Manhart et al., 2011). Also, students and people who had multiple sex
partners were reported as having higher levels of perceived susceptibility (Manhart et al., 2011).
Perceived severity. Perceived severity is the belief about how serious a condition and its
effects would be on an individual‟s health or life (Glanz, 2008). Perceived severity of HPV
infection is the belief about the seriousness of getting infected by HPV and developing genital
warts or cervical cancer. A question assessing the severity of HPV would be “If you got HPV,
how bad do you think it would be for your health?” (Manhart et al., 2011, p. 5239). Cohen and
Head (2013) showed that vaccinated and unvaccinated women were similar in their low
knowledge level and their fears about HPV and cervical cancer. In the research for young adult
women, 82% of participants believed HPV would result in negative influence on their health
(Manhart et al., 2011). Lee et al. (2014) demonstrated that perceiving cancer as a terrifying
disease is the primary reason people chose to get the HPV vaccination.
Perceived benefits. Perceived benefits are the belief in the advised action to reduce the risk
of seriousness of impact (Glanz, 2008). The perceived benefit of HPV vaccination is the belief
that getting the vaccine will reduce the risk of getting HPV and therefore reduce the risk of
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developing warts and cervical cancer. A question assessing the perceived benefit of HPV
vaccination would be “How effective do you think the HPV vaccine is in protecting women from
getting HPV?” (Manhart et al., 2011, p. 5239). Clinical trials reported the HPV vaccine provided
100% protection for the strains included in the vaccine (National Center for Immunization and
Respiratory Diseases, 2014).
Perceived barriers. Perceived barriers are the beliefs about the tangible and psychological
costs of the advised action to prevent health problems (Glanz, 2008). Perceived barriers for
receiving the HPV vaccination include time, embarrassment, and financial cost. STD-associated
stigma was considered the cause of embarrassment and functioned as a barrier to the general
public‟s hypothetical reception of a future HPV vaccine (Friedman & Shepeard, 2007). Belief
that the vaccine is less than 75% effective was considered a significant barrier for choosing to be
vaccinated among young adult women (Manhart et al., 2011). According to the World Health
Organization (WHO; 2013), during the communication experience of advertising the HPV
vaccination in some countries, people (especially parents) questioned the HPV vaccine because
they believed that the HPV vaccination would result in adolescents being less scared of getting
HPV and therefore be more sexually active. Safety of the new vaccine was another concern that
is identified as a barrier to HPV vaccination (WHO, 2013).
Niccolai, Mehta, and Hadler (2011) found that in the three doses of HPV vaccination, people
have more barriers in receiving the following two doses than receiving the first dose because of
the additional two visits needed. Scheduling additional visits to finish the whole three-dose
vaccination process may require more knowledge about HPV vaccination. Also, it requires more
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money to finish HPV vaccination. If the cost of the vaccine and transportation expenses can be
covered by health insurance or a government program, and adolescents can receive the
vaccination during parents‟ off work times, the vaccination rates are likely to be increased.
Cues to action. Cues to action are the strategies to activate “readiness”, stimulating people
to take action (Glanz, 2008). Cues to action for this study are factors that stimulate people to get
the HPV vaccine. Providing people with information about the high prevalence of HPV and the
association HPV has with cervical cancer has been shown to motivate people to take action
(Friedman & Shepeard, 2007). Peer influence was also found to be an important factor
contributing to people choosing to get the HPV vaccination. Cohen and Head (2013) reported
that HPV vaccinated women reported having a supportive interpersonal network of people with
positive attitudes and intentions to receive HPV vaccination themselves.
There is strong evidence that positive lifestyles can be considered as cues to action, which
make a difference in participants receiving the HPV vaccine (Donadiki et al., 2014).
Self-efficacy. Self-efficacy was defined as the confidence in one‟s ability to take action in
1977 by Bandura (Janz et al., 2002). Self-efficacy of HPV vaccination represents the confidence
in the ability to take action and get the HPV vaccination. Currently, there is no research clearly
mentioning self-efficacy in the research of HPV vaccination. However, Niccolai, Mehta, and
Hadler (2011) showed that to schedule the HPV requires motivation because HPV vaccination
required time and money to finish all three doses. They demonstrated that motivation plays an
important part in the HPV vaccination process.
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Summary
HPV is a common type of virus that can cause genital warts or develop into various types of
cancer. There are three kinds of HPV vaccinations licensed currently to prevent HPV infection.
Research into why people intend to get the HPV vaccine could help health professionals increase
vaccination rates and therefore decrease HPV infection and, specifically, cervical cancer.
The existing studies provide strong support for applying the HBM constructs to HPV
vaccination intention. Also, the current research provided enough evidence that the HBM
components were useful in analyzing people‟s intention to choose or not to choose HPV
vaccination.
Although HPV-related topics have become very popular in recent years, there were only a
few research studies that applied the Health Belief Model to HPV vaccination. The complete
Health Belief Model for HPV vaccination has only been applied in one research study (Donadiki
et al., 2014). At the time of this study, a comprehensive literature search found no published
research studies done in the United States addressing HBM on college females‟ intention or
likelihood to receive the HPV vaccination.
This study used the Health Belief Model to identify the main construct items and factors that
relate to the intentions of Eastern Michigan University‟s female undergraduates to receive the
HPV vaccine. This study provides information for interventions designed to increase HPV
vaccination rates in order to decrease HPV infection and cervical cancer.
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Chapter III: Methodology

Theoretical Framework
The Health Belief Model (HBM) was the theoretical framework used in the instrument‟s
development. All six constructs including perceived susceptibility, perceived severity, perceived
benefits, perceived barriers, cues to action, and self-efficacy were used in the study. This
theoretical framework helped explain behaviors related to HPV vaccination. Perceived
susceptibility represented the perception of risk of getting infected by HPV. Perceived severity
represented the belief, feeling, and concern of the seriousness of getting infected by HPV.
Perceived benefits showed the belief of positive consequences of HPV vaccination. Perceived
barriers were the internal and external obstacles of getting the HPV vaccine. Cues to action
referred to the stimulus needed to get the HPV vaccination. Self-efficacy represented the
confidence in the ability to take action and get the HPV vaccination.

Participants
The population of interest for this study was 18–26 year-old female undergraduate students
enrolled at Eastern Michigan University. The age range of undergraduate students was limited to
26 because the recommended age for the HPV vaccination for girls and women is 11–26 (The
Lancet Infectious Diseases, 2006). The total number of female undergraduates at EMU was
estimated to be 10,584 [18,569 undergraduates x .57 (% female)]. Among the female student
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enrollment for fall 2015, approximately 6,880 were estimated to be White [10,584 female
undergraduates x .65 (% White)], 2,223 Black [10,584 female undergraduates x .21 (% Black)],
265 Asian-American [10,584 female undergraduates x .025 (% Asian-American)], 212 Hispanic
[10,584 female undergraduates x .02 (% Hispanic)], and 53 Native-American [10,584 female
undergraduates x .005 (% Native-American)]. A priori power analysis, for external validity of the
results, determined an approximate sample size to minimize a Type II error (Raosoft, 2004). The
suggested sample size required for the study was calculated to be 371 respondents based on 5%
sampling error and 50/50 split in responses.

Instrument Development
This HPV Vaccination Belief Survey (Appendix A) was a cross-sectional study focusing on
the relationship between the Health Belief Model (HBM) constructs and HPV vaccine intention
among Eastern Michigan University female undergraduates. Instrument development was based
on the existing instruments developed to study Instrument Refinement for Breast Cancer
Screening Behaviors (Champion, 1993), Revised Susceptibility, Benefits and Barriers scale for
Mammography Screening (Champion, 1999), Development of a Self-efficacy Scale for
Mammography (Champion, 2005), and Health belief model applied to non-compliance with HPV
vaccine among female university students (Donadiki et al., 2012). Champion‟s Health Belief
Model constructs‟ instruments were developed to study breast cancer using the HBM constructs.
Champion updated the instruments several times; these updated instruments were used for this
study. Reliability and validity tests were completed by the original instrument developers.
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However, reliability and validity tests were not done for the instrument developed for this study.
Questions addressed each construct of the HBM, covering perceived susceptibility, perceived
severity, perceived benefits, perceived barriers, cues to action, and self-efficacy. Questions in the
existing instrument were slightly changed to adjust the topic for HPV research. For example, “It
is likely that I will get breast cancer” was changed to “It is likely that I will get HPV” in this
study. Also, health behavior questions asked in the research of Donadiki et al. (2012) were used
as questions for cues to action in this instrument. Questions about current relationship status,
visits to a gynecologist, and lifestyle were asked in the cues to action section.
In addition to the HBM constructs, the instrument was used to examine female
undergraduate status, age, race, GPA level, intention to get vaccine, and status of HPV
vaccination.

Instrument Structure
The online survey was developed in Eastern Michigan University Survey System. The
Eastern Michigan University Survey System program was an online survey development tool.
This program was a convenient way for EMU researchers to create, modify, and distribute a
research instrument.
The instrument is a seven page online survey. The first section (page 1) of the instrument is
an informed consent letter (Appendix B). The informed consent letter includes a summary
description of the research, potential risks of completing the study, who can be contacted with
questions, and an informed consent statement.
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The next section (Appendix A) examined the HBM constructs using a five-point scale to
measure responses (strongly disagree, disagree, neither agree nor disagree, agree, and strongly
agree). This section was four pages with 54 items. The first page of this section included a 3-item
scale to test perceived susceptibility of HPV and a 12-item scale to assess perceived seriousness
of HPV. The second page of this section included a 5-item scale to assess perceived benefits of
receiving the HPV vaccination and a 12-item scale to assess perceived barriers to receiving the
HPV vaccination. The final two pages of this section included a 10-item scale to assess cues to
action of getting the HPV vaccination and a 12-item scale to assess self-efficacy for receiving the
HPV vaccination.
The final section (Appendix A) of the survey (page 6) assessed the demographics of
participants and their intentions to get the HPV vaccine. There were six questions assessing
female undergraduate status, age, race, GPA level, intention to get vaccine, and status of HPV
vaccination.
The last page of the instrument (Appendix C) asked participants to leave their email address
if they would like to be entered into the raffle for gift cards. This page informed the participants
of the process for the raffle and that the email address given was not connected in any way to
their questionnaire.

Data Collection Procedure
Once this proposal was approved by my thesis committee (Appendix D) it was submitted to
the Eastern Michigan University Human Subjects Review Committee for approval (Appendix E).
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An Email Survey Request Form (Appendix F) was submitted through the Office of Research
Development and Administration requesting distribution of the email containing the survey link.
Once the Email Survey Request Form was approved by the Provost and Executive Vice President
of Academic Affairs, a description of the study, eligibility criteria, and a link to the survey in the
Eastern Michigan University Survey System with a raffle of three $100 Gift Cards was emailed
(Appendix G) to 8,889 female students currently enrolled at Eastern Michigan University. A
reminder email (Appendix H) was sent one week after data collection began.
Participation in this cross-sectional survey was completely voluntary. When participants
clicked on the link to the survey, the first section of the online survey showed up. The first
section of the online survey was an informed consent letter (Appendix B). Informed consent was
assumed when participants pressed the next button at the end of the informed consent. Once they
clicked on the next button, the questionnaire for this study (Appendix A) appeared. Once they
clicked on the next button at the end of the questionnaire, the raffle section (Appendix C) showed
up. Participants were asked to leave their email address if they wanted to be entered into the
raffle for gift cards. Data from the raffle section were separated from the HPV survey section to
ensure confidentiality. Participants who chose not to give their consent were given directions to
exit the instrument. It is estimated that the survey took 20 minutes to complete.
After two weeks, the researcher downloaded the results from the Eastern Michigan
University Survey System. Data were saved as Excel files and were transformed into SPSS files.
The files are stored in a locked cabinet in the researcher‟s room. All responses and demographic
information were kept confidential. The incentive winners were notified one week after the data

USE OF HEALTH BELIEF MODEL TO UNDERSTAND HPV VACCINE BEHAVIOR IN FEMALE UNDERGRADUATES

27

collection had finished. The final data of this research will be stored in a locked cabinet for five
years before being destroyed.

Data Analysis
Data analysis was performed using the Statistical Package for the Social Sciences (SPSS)
22.0 for Windows. Descriptive statistics were used to describe the characteristics of respondents
and their intention to get the HPV vaccine. Chi-Square Test for Independence was used to
determine whether or not the categorical variables are related. Chi square goodness-of-fit test
was used to compare demographic data in this research and EMU demographic data.
1. Research question: Is there any relationship between participants‟ perceived susceptibility
and their intentions to receive the HPV vaccination?
Null Hypothesis: There is no relationship between participants‟ perceived susceptibility and
their intentions to receive the HPV vaccination.
Hypothesis: Participants who have more perceived susceptibility have more intention to
receive the HPV vaccination.
Independent variable: participants‟ perceived susceptibility (SA----SD).
Dependent variable: participants‟ intentions to receive HPV vaccine (Yes/No)

2. Is there any relationship between participants‟ perceived severity and their intentions to
receive the HPV vaccination?
Null Hypothesis: There is no relationship between participants‟ perceived severity and their
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intentions to receive the HPV vaccination.
Hypothesis: Participants who have more perceived severity have more intention to receive
the HPV vaccination.
Independent variable: participants‟ perceived severity (SA----SD).
Dependent variable: participants‟ intentions to receive HPV vaccine (Yes/No)

3. Is there any relationship between participants‟ perceived benefits and their intentions to
receive the HPV vaccination?
Null Hypothesis: There is no relationship between participants‟ perceived benefits and their
intentions to receive the HPV vaccination.
Hypothesis: Participants who have more perceived benefits have more intention to receive
the HPV vaccination.
Independent variable: participants‟ perceived benefits (SA----SD).
Dependent variable: participants‟ intentions to receive HPV vaccine (Yes/No)

4. Is there any relationship between participants‟ perceived barriers and their intentions to
receive the HPV vaccination?
Null Hypothesis: There is no relationship between participants‟ perceived barriers and their
intentions to receive the HPV vaccination.
Hypothesis: Participants who have more perceived barriers have less intention to receive the
HPV vaccination.
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Independent variable: participants‟ perceived barriers (SA----SD).
Dependent variable: participants‟ intentions to receive HPV vaccine (Yes/No)

5. Is there any relationship between participants‟ perceived cues to action and their intentions to
receive the HPV vaccination?
Null Hypothesis: There is no relationship between participants‟ perceived cues to action and
their intentions to receive the HPV vaccination.
Hypothesis: Participants who have more perceived cues to action have more intention to
receive the HPV vaccination.
Independent variable: participants‟ perceived cues to action (SA----SD).
Dependent variable: participants‟ intentions to receive HPV vaccine (Yes/No)

6. Is there any relationship between participants‟ perceived self-efficacy and their intentions to
receive the HPV vaccination?
Null Hypothesis: There is no relationship between participants‟ perceived self-efficacy and
their intentions to receive the HPV vaccination.
Hypothesis: Participants who have more perceived self-efficacy have more intention to
receive the HPV vaccination.
Independent variable: participants‟ perceived self-efficacy (SA----SD).
Dependent variable: participants‟ intentions to receive HPV vaccine (Yes/No)
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7. Is there any relationship between participants‟ race and their intentions to receive the HPV
vaccination?
Null Hypothesis: There is no relationship between participants‟ race and their intentions to
receive the HPV vaccination.
Hypothesis: Participants who are White have more intention to receive the HPV vaccination.
Independent variable: race (White/ Non-white).
Dependent variable: participants‟ intentions to receive HPV vaccine (Yes/No)

8. Is there any relationship between participants‟ grade point average and their intentions to
receive the HPV vaccination?
Null Hypothesis: There is no relationship between participants‟ grade point average and their
intention to receive the HPV vaccination.
Hypothesis: Participants who have higher grade point average have more intention to receive
the HPV vaccination.
Independent variable: participants‟ GPA (4.0–3.5, 3.49–3, 2.99–2.5, under 2.5).
Dependent variable: participants‟ intentions to receive HPV vaccine (Yes/No)
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Chapter IV: Results

Response Rate
After the HPV Vaccination Belief Survey was distributed to 8,889 recipients by email, 1,427
respondents (16.1%) clicked “I consent” on the informed consent to participate in this study. Of
the 1,427 respondents, 1,144 participants finished the entire survey for a response rate of 12.8%.
Sample size was determined based on setting alpha at 0.05 and 95% power (Raosoft, 2004). The
suggested sample size, to reduce Type II error, was calculated to be 371 respondents based on 5%
sampling error and 50/50 split in responses. The number of surveys completed and used in data
analysis exceeded the suggested sample size.

Description of the Demographic Characteristics
The HPV Vaccination Belief Survey was completed by 1,144 participants, but 18
participants did not self-identify as female undergraduate students between 18 and 26, the target
population of this study. Thus, the final sample size for the study was 1,126. Two thirds (66%) of
participants were 18–21 years old. The majority of participants (78.8%) self-identified as White
and had a grade point average (GPA) between 3.0 and 4.0 (86.1%). Nearly half of participants
(48.5%) had already received the HPV vaccine while the remaining 51.5% reported they had not
received it. Of those reporting they received the vaccine, 72.9% reported that they had received
all three doses of the HPV vaccine. Of those reporting they had not received the vaccine, 34.8%
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indicated that they intend to get the HPV vaccine and 65.2% responded that they did not intend
to get it.

Table 1
Demographic Characteristics of Participants
Characteristics
Age
18-21
21-26
How do you describe or identify yourself
White
Black
Asian-American
Native-American
Hispanic
Grade point average (GPA)
3.0-4.0
2.0-2.99
Less than 2.0
Do you intend to get the HPV vaccine in the future?
Yes
No
I already got the vaccine
Have you received the HPV vaccination before?
One dose
Two doses
All three doses
The percentages may not add up to 100% due to rounding.

Number
n=1126
743
383
n=1126
887
158
39
6
36
n=1126
969
154
3
n=1126
202
378
546
n=646
108
67
471

Percent
66.0
34.0
78.8
14.0
3.5
0.5
3.2
86.1
13.7
0.3
17.9
33.6
48.5
16.7
10.3
72.9

The number of participants (48.5%) who answered “I already got the vaccine” is not
consistent with the total number of people who reported receiving one or more doses of the HPV
vaccination (57.4%). Participants that did not receive all three doses might have responded that
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they had not gotten the vaccine. On the other hand, participants could have also responded they
had gotten the vaccine even though they hadn‟t had all the doses. While the data collection
methods differ, the HPV vaccination rate of the participants in this study (48.5%–57.4%) is
similar with the national undergraduate students‟ HPV vaccination rate (51.1%) reported by the
ACHA data collected at EMU (2014).
The race/ethnicity of participants is presented in Table 2. The majority of participants were
White (78.8%) with the next highest group being Black (14%). When compared with the
demographic make-up of Eastern Michigan University students, more Whites and fewer Blacks
are represented in the study. The other races/ethnicities represented in the study were similar to
the percentages represented at EMU, Asian-American, Hispanic, and Native-American.

Table 2
Chi Square Goodness-of-fit Test for Race
Race

Observed N

Expected N

White

887

804.2

82.8

Black

158

259.8

-101.8

Asian

39
36
6
1126

31.0
24.8
6.2
1126

8.0
11.2
-.2

Hispanic
Native_American
Total

Residual

Observed N was based on the current study‟s final sample
Expected N was based on EMU demographic data
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Health Belief Model Constructs
In the HPV Vaccination Belief Survey, participants were asked to select the best match to
their level of agreement with the statements related to each construct of the Health Belief Model.
While each table presents the descriptive results for each level of agreement, data were collapsed
into three levels of agreement for practical application in the text. The three groups are those who
agree (strongly agree and agree), those who disagree (strongly disagree and disagree), and those
who neither agree nor disagree. Descriptive statistics were used to describe participants‟
responses for all of the Health Belief Model construct items.
Perceived susceptibility. In the HPV Vaccination Belief Survey, participants were asked to
select the best match to their level of agreement with the statements related to perceived
susceptibility of getting HPV (Table 3). The majority of the respondents did not perceive
themselves to be susceptible to getting HPV by disagreeing with all three statements: My
chances of getting HPV in the next few years are great (78.7%), I feel I will get HPV sometime
during my life (75.6%), and It is likely that I will get HPV (73.1%).
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Table 3
Perceived Susceptibility of Getting HPV
Item

SD
D
NANDA
A
SA
484
339
156
66
81
It is likely that I will get HPV.
(43.0%)
(30.1%)
(13.9%)
(5.9%)
(7.2%)
My chances of getting HPV in the
551
335
135
70
35
next few years are great.
(48.9%)
(29.8%)
(12.0%)
(6.2%)
(3.1%)
I feel I will get HPV sometime
499
352
171
53
51
during my life.
(44.3%)
(31.3%)
(15.2%)
(4.7%)
(4.5%)
SD: Strongly Disagree; D: Disagree; NANDA: Neither Agree Nor Disagree; A: Agree; SA:
Strongly Agree
The percentages may not add up to 100% due to rounding.
N= 1126

Perceived severity. In the HPV Vaccination Belief Survey, participants were asked to select
the best match to their level of agreement with the statements related to perceived severity of
getting genital warts or developing cervical cancer(Table 4). The majority of participants agreed
with 7 out of the 12 statements: The thought of genital warts or cervical cancer scares me
(91.9%), If I had cervical cancer, my whole life would change (83.1%), Genital warts or cervical
cancer would endanger my love relationships (79.7%), Problems I would experience from
cervical cancer would last a long time (76.3%), My financial security would be endangered if I
got cervical cancer (66.2%), My feelings about myself would change if I got cervical cancer
(58.2%), If I had genital warts or cervical cancer my academics and career would be
endangered (53.6%). The majority of participants disagreed with one statement: Cervical cancer
is a hopeless disease (54.3%) while one third (32.7%) did not agree or disagree with that
statement. There was more variation in responses for the rest of the statements. Participants were
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more likely to agree than to disagree with the following three items: When I think about genital
warts or cervical cancer I feel nauseous (49.8% agree vs. 27.9% disagree), I am afraid to even
think about cervical cancer (44.8% agree vs. 35.9% disagree), and If I got cervical cancer, it
would be more serious than other diseases (44.2% agree vs. 17%). Participants were equally split
in response to the following statement: When I think about genital warts or cervical cancer my
heart beats faster (35.9% agree vs. 35.4% disagree).
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Table 4
Perceived Severity of Getting Genital Warts or Developing Cervical Cancer
Item
The thought of genital warts or cervical
cancer scares me.
When I think about genital warts or cervical
cancer I feel nauseous.
If I had genital warts or cervical cancer my
academics and career would be endangered.
When I think about genital warts or cervical
cancer my heart beats faster.
Genital warts or cervical cancer would
endanger my love relationships.
Cervical cancer is a hopeless disease.

SD
D
NANDA
A
SA
17
28
46
357
678
(1.5%) (2.5%)
(4.1%) (31.7%) (60.2%)
57
257
251
349
212
(5.1%) (22.8%) (22.3%) (31.0%) (18.8%)
70
210
242
427
177
(6.2%) (18.7%) (21.5%) (37.9%) (15.7%)
88
311
322
274
131
(7.8%) (27.6%) (28.6%) (24.3%) (11.6%)
29
81
118
446
452
(2.6%) (7.2%) (10.5%) (39.6%) (40.1%)
131
481
368
111
35
(11.6%) (42.7%) (32.7%) (9.9%) (3.1%)
My feelings about myself would change if I
65
216
190
455
200
got cervical cancer.
(5.8%) (19.2%) (16.9%) (40.4%) (17.8%)
I am afraid to even think about cervical
84
320
218
333
171
cancer.
(7.5%) (28.4%) (19.4%) (29.6%) (15.2%)
My financial security would be endangered
37
142
202
430
315
if I got cervical cancer.
(3.3%) (12.6%) (17.9%) (38.2%) (28.0%)
Problems I would experience from cervical
10
47
210
575
284
cancer would last a long time.
(0.9%) (4.2%) (18.7%) (51.1%) (25.2%)
If I got cervical cancer, it would be more
28
163
437
374
124
serious than other diseases.
(2.5%) (14.5%) (38.8%) (33.2%) (11.0%)
If I had cervical cancer, my whole life
11
62
117
574
362
would change.
(1.0%) (5.5%) (10.4%) (51.0%) (32.1%)
SD: Strongly Disagree; D: Disagree; NANDA: Neither Agree Nor Disagree; A: Agree; SA:
Strongly Agree
The percentages may not add up to 100% due to rounding.
N= 1126

Perceived benefits. In the HPV Vaccination Belief Survey, participants were asked to select
the best match to their level of agreement with the statements related to the perceived benefits of
HPV vaccination (Table 5). The majority of participants agreed with all statements related to
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perceived benefits of the HPV vaccination. Three out of four participants agreed with the
statement: Receiving vaccinations will help me prevent diseases (78.7%). More than half of
participants agreed with the following statements: Having the HPV vaccination will decrease my
chances of dying from cervical cancer (61.1%), If I receive the HPV vaccine, I would not worry
as much about cervical cancer (59.2 %), Having the HPV vaccination is the best way for me to
prevent HPV and cervical cancer (55%), and If I receive the HPV vaccine, my treatment for HPV
may not be as bad (50.1%).

Table 5
Perceived Benefits of HPV Vaccination
Item
SD
D
NANDA
A
SA
If I receive the HPV vaccine, I would not
61
180
219
501
165
worry as much about cervical cancer.
(5.4%) (16.0%) (19.4%) (44.5%) (14.7%)
Receiving vaccinations will help me prevent
28
70
142
553
333
diseases.
(2.5%) (6.2%) (12.6%) (49.1%) (29.6%)
If I receive the HPV vaccine, my treatment
35
124
403
451
113
for HPV may not be as bad.
(3.1%) (11.0%) (35.8%) (40.1%) (10.0%)
Having the HPV vaccination is the best way
80
171
256
393
226
for me to prevent HPV and cervical cancer.
(7.1%) (15.2%) (22.7%) (34.9%) (20.1%)
Having the HPV vaccination will decrease
42
109
287
492
196
my chances of dying from cervical cancer.
(3.7%) (9.7%) (25.5%) (43.7%) (17.4%)
SD: Strongly Disagree; D: Disagree; NANDA: Neither Agree Nor Disagree; A: Agree; SA:
Strongly Agree
The percentages may not add up to 100% due to rounding.
N= 1126

Perceived barriers. In the HPV Vaccination Belief Survey, participants were asked to select
the best matches to their level of agreement with the statements related to the perceived barriers
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to receiving the HPV vaccination (Table 6). The majority of the participants disagreed with ten of
twelve statements: Receiving the HPV vaccination is too embarrassing because it is STD related
(85.2%), I am afraid to receive the HPV vaccination because I might find out I’m carrying HPV
already (84.4%), I do not know if I already had the HPV vaccination (80.3%), Receiving the
HPV vaccination takes too much time (77%), I am afraid to receive the HPV vaccination because
I don’t understand the three-dose procedure (75.4%), I don’t know how to go about receiving the
HPV vaccination (71.5%), Receiving the HPV vaccination is too painful (68.7%), I am afraid to
receive the HPV vaccination because I don’t think HPV vaccine is effective (66.5%), I am afraid
to receive the HPV vaccination because I don’t think HPV vaccine is safe (63.8%), and I cannot
remember to schedule the HPV vaccination (57.3%). Nearly half of participants disagreed with
the statement Receiving the HPV vaccination is expensive (48.9% disagree vs. 18.8% agree).
Participants had a higher rate of agreement with the statement Receiving the HPV vaccination
can cause reactions (40.3% agree vs. 26.3% disagree).
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Table 6
Perceived Barriers to Receiving the HPV Vaccine
Item
SD
D
NANDA
A
SA
I am afraid to receive the HPV vaccination
531
419
110
54
12
because I might find out I‟m carrying HPV (47.2%) (37.2%) (9.8%)
(4.8%) (1.1 %)
already.
I am afraid to receive the HPV vaccination
435
415
139
113
24
because I don‟t understand the three-dose
(38.6%) (36.9%) (12.3%) (10.0%) (2.1%)
procedure.
I don‟t know how to go about receiving the
432
373
88
192
41
HPV vaccination.
(38.4%) (33.1%) (7.8%) (17.1%) (3.6%)
Receiving the HPV vaccination is too
566
393
94
65
8
embarrassing because it is STD related.
(50.3%) (34.9%) (8.3%)
(5.8%) (0.7%)
Receiving the HPV vaccination takes too
452
416
164
88
6
much time.
(40.1%) (36.9%) (14.6 %) (7.8%) (0.5%)
Receiving the HPV vaccination is too
401
373
227
98
27
painful.
(35.6%) (33.1%) (20.2%) (8.7%) (2.4%)
Receiving the HPV vaccination is
287
263
365
181
30
expensive.
(25.5%) (23.4%) (32.4%) (16.1%) (2.7%)
Receiving the HPV vaccination can cause
133
163
377
352
101
reactions.
(11.8%) (14.5%) (33.5%) (31.3%) (9.0%)
I cannot remember to schedule the HPV
363
395
209
138
21
vaccination.
(32.2%) (25.1%) (18.6%) (12.3%) (1.9%)
I am afraid to receive the HPV vaccination
360
389
226
110
41
because I don‟t think HPV vaccine is
(32.0%) (34.5 %) (20.1%) (9.8%) (3.6%)
effective.
I am afraid to receive the HPV vaccination
361
357
208
129
71
because I don‟t think HPV vaccine is safe.
(32.1%) (31.7%) (18.5%) (11.5%) (6.3%)
I do not know if I already had the HPV
602
302
84
101
37
vaccination
(53.5%) (26.8%) (7.5%)
(9.0%) (3.3%)
SD: Strongly Disagree; D: Disagree; NANDA: Neither Agree Nor Disagree; A: Agree; SA:
Strongly Agree
The percentages may not add up to 100% due to rounding.
N= 1126
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Cues to action. In the HPV Vaccination Belief Survey, participants were asked to select the
best match to their level of agreement with the statements related to cues to action for getting the
HPV vaccine (Table 7). The majority of participants agreed with 7 out of 10 statements: I am
currently employed (74.4%), I frequently do things to improve my health (71.4%), I received
HPV-related information (66.8%), I received HPV vaccination related information (66.2%), My
doctor has suggested I get the HPV vaccine (60.3%), I have a stable relationship (57.5%), and I
have visited a gynecologist (55.9%). The majority of participants disagreed with the statements:
My friends have suggested I get the HPV vaccine (65.6%). There was more variation in
responses for the two statements: My parents have suggested I get the HPV vaccine (42.8%
disagree vs. 40.2% agree) and I make sure a condom is used each time someone has anal, oral,
or vaginal sex with me (38.3% agree vs. 36.7% disagree).
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Table 7
Cues to Action for Getting the HPV Vaccine
Item
I have a stable relationship.
I have visited a gynecologist.
I am currently employed.
I make sure a condom is used each time
someone has anal, oral or vaginal sex with
me.
I frequently do things to improve my
health.
I received HPV related information.

SD
129
(11.5%)
192
(17.1%)
76
(6.7%)
94
(8.3%)

D
196
(17.4%)
272
(24.2%)
172
(15.3%)
320
(28.4%)

NANDA
154
(13.7%)
32
(2.8%)
40
(3.6%)
280
(24.9%)

A
188
(16.7%)
221
(19.6%)
336
(29.8%)
219
(19.4%)

SA
459
(40.8%)
409
(36.3%)
502
(44.6%)
213
(18.9%)

7
77
238
554
250
(0.6%)
(6.8%)
(21.1%) (49.2%) (22.2%)
66
197
111
482
270
(5.9%) (17.5%)
(9.9%) (42.8%) (24.0%)
I received HPV vaccination related
69
201
111
475
270
information.
(6.1%) (17.9%)
(9.9%) (42.2%) (24.0%)
My friends have suggested I get the HPV
318
421
240
106
41
vaccine.
(28.2%) (37.4%) (21.3%) (9.4%) (3.6%)
My doctor has suggested I get the HPV
129
168
149
380
300
vaccine.
(11.5%) (14.9%) (13.2%) (33.7%) (26.6%)
My parents have suggested I get the HPV
237
246
191
252
200
vaccine.
(21.0%) (21.8%) (17.0%) (22.4%) (17.8%)
SD: Strongly Disagree; D: Disagree; NANDA: Neither Agree Nor Disagree; A: Agree; SA:
Strongly Agree
The percentages may not add up to 100% due to rounding.
N= 1126

Self-efficacy. In the HPV Vaccination Belief Survey, participants were asked to select the
best match to their level of agreement with the statements related to self-efficacy of getting the
HPV vaccine (Table 8). The majority of participants agreed with all 12 statements related to
self-efficacy of getting the HPV vaccine: I know for sure I can get the HPV vaccination if I really
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want to (89.3%), I can receive the HPV vaccination even if I don’t know what to expect (87.5%),
I can make an appointment for the HPV vaccination (86.7%), I can talk to a professional about
my concerns (85.9%), I can arrange transportation to receive the HPV vaccination (85.8%), I
can find a place to get the HPV vaccination (84.9%), I can receive the HPV vaccination even if I
am worried (83.8%), I can find a way to pay for the HPV vaccination (83.6%), I can arrange
other things in my life to receive the HPV vaccination (83%), I know how to go about getting the
HPV vaccination (76.2%), I can get the HPV vaccine if I am 26 years old or under (71.5%),and I
can get the HPV vaccine even if I did not get all of it when I was younger (69.9%).
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Table 8
Self-Efficacy of Getting the HPV Vaccine
Item
SD
D
NANDA
A
SA
I can arrange transportation to receive the
26
41
93
546
420
HPV vaccination.
(2.3%)
(3.6%)
(83%)
(48.5%) (37.3%)
I can arrange other things in my life to
22
43
127
546
388
receive the HPV vaccination.
(2.0%)
(3.8%)
(11.3%) (48.5%) (34.5%)
I can talk to a professional about my
17
42
100
581
386
concerns.
(1.5%)
(3.7%)
(8.9%) (51.6%) (34.3%)
I can receive the HPV vaccination even if
25
37
120
580
364
I am worried.
(2.2%)
(3.3%) (10.7%) (51.5%) (32.3%)
I can receive the HPV vaccination even if
34
80
139
541
332
I don‟t know what to expect.
(3.0%)
(7.1%) (12.3%) (48.0%) (29.5 %)
I can find a way to pay for the HPV
40
85
173
529
299
vaccination.
(3.6%)
(7.5%) (15.4%) (47.0%) (26.6%)
I can make an appointment for the HPV
11
27
112
616
360
vaccination.
(1.0%)
(2.4%)
(9.9%) (54.7%) (32.0%)
I know for sure I can get the HPV
12
26
83
565
440
vaccination if I really want to.
(1.1%)
(2.3%)
(7.4%) (50.2 %) (39.1%)
I know how to go about getting the HPV
35
137
97
478
379
vaccination.
(3.1%) (12.2%) (8.6%) (42.5%) (33.7%)
I can find a place to get the HPV
13
57
101
558
397
vaccination.
(1.2%)
(5.1%)
(9.0%) (49.6%) (35.3%)
I can get the HPV vaccine even if I did not
11
22
305
505
283
get all of it when I was younger.
(1.0%)
(2.0%) (27.1%) (44.8%) (25.1%)
I can get the HPV vaccine if I am 26 years
7
26
288
525
280
old or under.
(0.6%)
(2.3%) (25.6%) (46.6%) (24.9%)
SD: Strongly Disagree; D: Disagree; NANDA: Neither Agree Nor Disagree; A: Agree; SA:
Strongly Agree
The percentages may not add up to 100% due to rounding.
N= 1126
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Results of Research Questions
Research question 1. Is there any relationship between their intentions to receive the HPV
vaccination and participants‟ perceived susceptibility? (Table 9)
Null Hypothesis: There is no relationship between their intentions to receive the HPV
vaccination and participants‟ perceived susceptibility.
Hypothesis: Participants who have more perceived susceptibility have more intention to
receive the HPV vaccination.
Independent variable: participants‟ perceived susceptibility (SA----SD).
Dependent variable: participants‟ intentions to receive HPV vaccine (Yes/No)
Chi-Square Test for Independence was used to determine whether or not participants‟
perceived susceptibility related to their intention to receive the HPV vaccination. Significant
relationships were found between participant‟s intention to receive the HPV vaccine and
participants‟ agreement levels with the following three statements reflecting participants‟
perceived susceptibility: It is likely that I will get HPV (χ2 (4, n=580) =36.215, p = .000 < .05),
My chances of getting HPV in the next few years are great (χ2 (4, n=580) =27.157, p = .000
< .05), and I feel I will get HPV sometime during my life (χ2 (4, n=580) =28.786, p = .000 < .05).
The null hypothesis was rejected since all three items were significant (p < .05). Participants‟
intentions to receive the HPV vaccine and participants‟ perceived susceptibility of getting
infected by HPV were related. Participants who had an intention to receive the HPV vaccination
agreed more and disagreed less to the statements that represented perceived susceptibility of
HPV.
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Table 9
Relationship Between Intention to Receive the HPV Vaccine and Perceived Susceptibility of
Getting HPV
Items

Options

It is likely that I will get SD
HPV.
D
NANDA
A
SA
My chances of getting
HPV in the next few years
are great.

I feel I will get HPV
sometime during my life.

SD
D
NANDA
A
SA
SD
D
NANDA
A
SA

Intend
(Expected
frequency)
66 (88)
58 (63)
48 (35)
21 (10) *
9 (6)
78 (100)
67 (63)
28 (21)
26 (14) *
3 (4)
64 (91)
68 (63)
49 (34)
16 (10) *
5 (4)

Not Intend
(Expected
frequency)
186 (164) *
124 (119)
52 (65)
9 (20)
7 (10)
209 (187) *
115 (119)
33 (40)
14 (26)
7 (6)
197 (170) *
112 (117)
48 (63)
13 (19)
8 (9)

Value
(χ2)

p

n=580

36.215 .000
n=580

27.157 .000
n=580

28.786 .000
SD: Strongly Disagree; D: Disagree; NANDA: Neither Agree Nor Disagree; A: Agree; SA:
Strongly Agree
Statistical significance of Chi Square of Independence test is based on p value of .05
*: has both statistical (differences between the observed and expected frequencies for those who
intend/not intend for the same row based on z-score) and practical significance (applicable
meaning).

Research question 2. Is there any relationship between their intentions to receive the HPV
vaccination and participants‟ perceived severity?
Null Hypothesis: There is no relationship between their intentions to receive the HPV
vaccination and participants‟ perceived severity.
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Hypothesis: Participants who have more perceived severity have more intention to receive
the HPV vaccination.
Independent variable: participants‟ perceived severity (SA----SD).
Dependent variable: participants‟ intentions to receive HPV vaccine (Yes/No)
Chi-Square Test for Independence was used to determine whether or not participants‟
perceived severity related to their intention to receive the HPV vaccination. According to Table
10, significant relationships were found between participant‟s intention to receive the HPV
vaccination and participants‟ agreement levels with the following 11/12 statements that reflected
participants‟ perceived severity on HPV-related diseases: The thought of genital warts or
cervical cancer scares me (χ2 (4, n=580) =19.216, p = .001 < .05), When I think about genital
warts or cervical cancer, I feel nauseous (χ2 (4, n=580) =14.580, p = .006 < .05), If I had genital
warts or cervical cancer, my academics and career would be endangered (χ2 (4, n=580) =25.990,
p = .000 < .05), When I think about genital warts or cervical cancer, my heart beats faster (χ2 (4,
n=580) =32.303, p = .000 < .05), Genital warts or cervical cancer would endanger my love
relationships (χ2 (4, n=580) =10.925, p = .027 < .05), Cervical cancer is a hopeless disease (χ2 (4,
n=580) =19.293, p = .001 < .05), My feelings about myself would change if I got cervical cancer
(χ2 (4, n=580) =12.234, p = .016 < .05), I am afraid to even think about cervical cancer (χ2 (4,
n=580) =33.142, p = .000 < .05), My financial security would be endangered if I got cervical
cancer (χ2 (4, n=580) =15.038, p = .005 < .05), Problems I would experience from cervical
cancer would last a long time (χ2 (4, n=580) =9.772, p = .044 < .05), and If I had cervical cancer,
my whole life would change (χ2 (4, n=580) =21.767, p = .000 < .05). The null hypothesis was
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rejected since these 11 statements were statistically significant. Based on these 11 statements,
participants‟ intentions to receive the HPV vaccination and participants‟ perceived severity were
related. Participants who had an intention to receive the HPV vaccination agreed more and
disagreed less to the 11 statements that represent perceived severity of HPV. Although
participants who had an intention to receive the HPV vaccination also agreed more and disagreed
less to the statement: If I got cervical cancer, it would be more serious than other diseases (χ2 (4,
n=580) =5.476, p = .242 > .05), there was no significant relationship between their intention to
receive the HPV vaccine and this statement of perceived severity.
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Table 10
Relationship Between Intention to Receive the HPV Vaccine and Perceived Severity of Getting
Genital Warts or Developing Cervical Cancer
Items

Options

The thought of genital warts SD
or cervical cancer scares
D
me.
NANDA
A
SA
When I think about genital
warts or cervical cancer I
feel nauseous.

If I had genital warts or
cervical cancer my
academics and career would
be endangered.

When I think about genital
warts or cervical cancer my
heart beats faster.

Genital warts or cervical
cancer would endanger my
love relationships.

SD
D
NANDA
A
SA
SD
D
NANDA
A
SA
SD
D
NANDA
A
SA
SD
D
NANDA
A
SA

Intend
(Expected
frequency)
0 (4)
3 (7)
6 (11)
55 (63)
138 (118) *
6 (13)
41(49)
40 (44)
72 (64)
43 (32) *
4 (15)
27 (37)
40 (41)
86 (77)
45 (32)*
10 (20)
49 (60)
49 (55)
57 (45) *
37 (22)*
4 (7)
10 (17)
22 (22)
76 (79)
90 (77) *

Not Intend
(Expected
frequency)
10 (6)*
16 (12)
27 (22)
125 (117)
200 (220)
30 (23) *
99 (91)
87 (83)
112 (120)
50 (61)
39 (28) *
79 (69) *
77 (76)
136 (145)
47 (60)
48 (38)*
122 (111) *
109 (103)
73 (85)
26 (41)
17 (14)
40 (33)*
40 (40)
151 (148)
130 (143)

Value
(χ2)

p

n=580

19.216
n=580

.001

14.580
n=580

.006

25.990
n=580

.000

32.303
n=580

.000

10.925

.027
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Table 10 continued
Items

Options

Cervical cancer is a
hopeless disease.

SD
D
NANDA
A
SA

My feelings about myself
would change if I got
cervical cancer.

I am afraid to even think
about cervical cancer.

SD
D
NANDA
A
SA
SD
D
NANDA
A
SA

My financial security would SD
be endangered if I got
D
cervical cancer.
NANDA
A
SA
Problems I would
experience from cervical
cancer would last a long
time.

If I got cervical cancer, it
would be more serious than
other diseases.

SD
D
NANDA
A
SA
SD
D
NANDA
A
SA

Intend
(Expected
frequency)
18 (26)
78 (86)
66 (64)
27 (18) *
13 (7)*
10 (14)
37 (39)
28 (35)
76 (77)
51 (37)*
9 (19)
44 (58)
39 (40)
58 (53)
52 (32) *
7 (8)
21 (25)
29 (35)
66 (76)
79 (59) *
3 (3)
6 (8)
30 (40)
103 (103)
60 (48) *
4 (6)
26 (33)
80 (78)
66 (64)
26 (21)

Not Intend
(Expected
frequency)
57 (49)*
170 (162)
118 (120)
26 (35)
7 (13)
30 (26)
76 (74)
72 (65)
145 (144)
55 (69)
45 (35) *
123 (109)*
77 (76)
93 (98)
40 (60)
15 (14)
51 (47)
71 (65)
151 (141)
90 (110)
5 (5)
18 (16)
85 (75)
193 (193)
77 (89)
14 (12)
68 (61)
145 (147)
117 (119)
34 (39)

Value
(χ2)

p

n=580

19.293
n=580

.001

12.234
n=580

.016

33.142
n=580

.000

15.038
n=580

.005

9.772
n=580

.044

5.476

.242
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Table 10 continued
Items

Options

If I had cervical cancer, my
whole life would change.

SD
D
NANDA
A
SA

Intend
(Expected
frequency)
2 (2)
6 (12)
20 (21)
85 (102)
89 (66) *

Not Intend
(Expected
frequency)
3 (3)
28 (22)
41 (40)
207 (190)
99 (122)

Value
(χ2)

p

n=580

21.767 .000
SD: Strongly Disagree; D: Disagree; NANDA: Neither Agree Nor Disagree; A: Agree; SA:
Strongly Agree
Statistical significance of Chi Square of Independence test is based on p value of .05
*: has both statistical (differences between the observed and expected frequencies for those who
intend/not intend for the same row based on z-score) and practical significance (applicable
meaning).

Research question 3. Is there any relationship between their intentions to receive the HPV
vaccination and participants‟ perceived benefits?
Null Hypothesis: There is no relationship between their intentions to receive the HPV
vaccination and participants‟ perceived benefits.
Hypothesis: Participants who have more perceived benefits have more intention to receive
the HPV vaccination.
Independent variable: participants‟ perceived benefits (SA----SD).
Dependent variable: participants‟ intentions to receive HPV vaccine (Yes/No)
Chi-Square Test for Independence was used to determine whether or not participants‟
perceived benefits related to their intention to receive the HPV vaccination. According to Table
11, significant relationships were found between participants‟ intention to receive the HPV
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vaccination and participants‟ agreement levels with all five statements that reflected participants‟
perceived benefits: If I receive the HPV vaccine, I would not worry as much about cervical
cancer (χ2 (4, n=580) =108.703, p = .000 < .05), Receiving vaccinations will help me prevent
diseases (χ2 (4, n=580) =59.540, p = .000 < .05), If I receive the HPV vaccine, my treatment for
HPV may not be as bad (χ2 (4, n=580) =68.828, p = .000 < .05), Having the HPV vaccination is
the best way for me to prevent HPV and cervical cancer (χ2 (4, n=580) =111.497, p = .000 < .05),
and Having the HPV vaccination will decrease my chances of dying from cervical cancer (χ2 (4,
n=580) =76.996, p = .000 < .05). The null hypothesis was rejected since these five statements
were significant. Participants‟ intentions to receive the HPV vaccination and participants‟
perceived benefits were related. Participants who had an intention to receive the HPV
vaccination agreed more and disagreed less to all five statements that represent perceived
benefits of HPV.
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Table 11
Relationship Between Intention to and Perceived Benefits of Receiving the HPV Vaccine
Items

Options

If I receive the HPV vaccine, I would
not worry as much about cervical
cancer.

SD
D
NANDA
A
SA

Receiving vaccinations will help me
prevent diseases.

If I receive the HPV vaccine, my
treatment for HPV may not be as bad.

Having the HPV vaccination is the best
way for me to prevent HPV and
cervical cancer.

Having the HPV vaccination will
decrease my chances of dying from
cervical cancer.

SD
D
NANDA
A
SA
SD
D
NANDA
A
SA
SD
D
NANDA
A
SA
SD
D
NANDA
A
SA

Intend
(Expected
frequency)
3 (20)
22 (50)
44 (50)
101 (69) *
32 (14) *
0 (9)
5 (20)
25 (31)
104 (100)
68 (41) *
2 (11)
8 (28)
69 (79)
96 (70) *
27 (14) *
5 (24)
19 (41)
48 (60)
83 (56) *
47 (21)*
1 (13)
13 (26)
43 (64)
110 (80) *
35 (19) *

Not Intend
(Expected
frequency)
54 (37) *
121 (93) *
100 (94)
96 (128)
7 (25)
26 (17) *
53 (38) *
64 (58)
184 (188)
51 (78)
30 (21) *
72 (52) *
158 (148)
105 (131)
13 (26)
64 (45) *
98 (76) *
123 (111)
79 (106)
14 (40)
37 (25)*
61 (48)*
142 (121)
119 (149)
19 (35)

Value
(χ2)

p

n=580

108.703 .000
n=580

59.540
n=580

.000

68.828
n=580

.000

111.497 .000
n=580

76.996 .000
SD: Strongly Disagree; D: Disagree; NANDA: Neither Agree Nor Disagree; A: Agree; SA:
Strongly Agree
Statistical significance of Chi Square of Independence test is based on p value of .05
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*: has both statistical (differences between the observed and expected frequencies for those who
intend/not intend for the same row based on z-score) and practical significance (applicable
meaning).

Research question 4. Is there any relationship between their intentions to receive the HPV
vaccination and participants‟ perceived barriers?
Null Hypothesis: There is no relationship between their intentions to receive the HPV
vaccination and participants‟ perceived barriers.
Hypothesis: Participants who have more perceived barriers have less intention to receive the
HPV vaccination.
Independent variable: participants‟ perceived barriers (SA----SD).
Dependent variable: participants‟ intentions to receive HPV vaccine (Yes/No)
Chi-Square Test for Independence was used to determine whether or not participants‟
perceived barriers related to their intention to receive the HPV vaccination (Table 12).
Significant relationships were found between participants‟ intention to receive the HPV
vaccination and participants‟ agreement levels with the following 8/12 statements that reflected
participants‟ perceived barriers: I am afraid to receive the HPV vaccination because I might find
out I’m carrying HPV already (χ2 (4, n=580) =11.698, p = .020 < .05), I don’t know how to go
about receiving the HPV vaccination (χ2 (4, n=580) =21.382, p = .000 < .05), Receiving the HPV
vaccination takes too much time (χ2 (4, n=580) =9.773, p = .044 < .05), Receiving the HPV
vaccination can cause reactions (χ2 (4, n=580) =33.884, p = .000 < .05), I cannot remember to
schedule the HPV vaccination (χ2 (4, n=580) =33.891, p = .000 < .05), I am afraid to receive the
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HPV vaccination because I don’t think HPV vaccine is effective (χ2 (4, n=580) =69.382, p = .000
< .05), I am afraid to receive the HPV vaccination because I don’t think HPV vaccine is safe (χ2
(4, n=580) =90.252, p = .000 < .05), and I do not know if I already had the HPV vaccination (χ2
(4, n=580) =33.534, p = .000 < .05). The null hypothesis was rejected since p < .05 in these 8
statements. Although 8/12 (66.7%) perceived barrier statements showed statistical significance,
when the relationship between cells was examined, there were only three statements that showed
practical significance: Receiving the HPV vaccination can cause reactions, I am afraid to receive
the HPV vaccination because I don’t think HPV vaccine is effective, and I am afraid to receive
the HPV vaccination because I don’t think HPV vaccine is safe. Participants who believe the
HPV vaccination causes reactions, do not think the HPV vaccine is effective, or do not think the
HPV vaccine to be safe have less intention of getting the HPV vaccine. Moreover, participants‟
responses to the statements: I am afraid to receive the HPV vaccination because I don’t
understand the three-dose procedure (χ2 (4, n=580) =2.752, p = .600 > .05), Receiving the HPV
vaccination is too embarrassing because it is STD related (χ2 (4, n=580) =1.799, p = .773 > .05),
Receiving the HPV vaccination is too painful (χ2 (4, n=580) =5.442, p = .245 > .05), and
Receiving the HPV vaccination is expensive (χ2 (4, n=580) =8.151, p = .086 > .05) had no
relationship with participants‟ intention to receive the HPV vaccination since p > .05 in these
four statements.
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Table 12
Relationship Between Intention to and Perceived Barriers of Receiving the HPV Vaccine
Items

Options

I am afraid to receive the HPV
vaccination because I might find
out I‟m carrying HPV already.

SD
D
NANDA
A
SA

I am afraid to receive the HPV
vaccination because I don‟t
understand the three-dose
procedure.

I don‟t know how to go about
receiving the HPV vaccination.

Receiving the HPV vaccination is
too embarrassing because it is STD
related.

Receiving the HPV vaccination
takes too much time.

SD
D
NANDA
A
SA
SD
D
NANDA
A
SA
SD
D
NANDA
A
SA
SD
D
NANDA
A
SA

Intend
(Expected
frequency)
69 (79)
75 (81)
33 (24)
19 (15)
6 (4)
50 (51)
72 (71)
36 (36)
33 (36)
11 (8)
36 (47)
62 (64)
16 (21)
63 (57)
25 (14) *
84 (77)
74 (79)
23 (25)
18 (18)
3 (2)
58 (54)
82 (79)
31 (44)
28 (23)
3 (1.7)

Not Intend
(Expected
frequency)
158 (148)
156 (150)
35 (44)
24 (28)
5 (7)
97 (96)
131 (132)
68 (68)
71 (68)
11 (14)
98 (87)
122 (120)
44 (39)
100 (106)
14 (25)
138 (145)
152 (147)
49 (47)
35 (35)
4 (5)
97 (101)
145 (148)
96 (83)
38 (43)
2 (3.3)

Value
(χ2)

p

n=580

11.698
n=580

.020

2.752
n=580

.600

21.382
n=580

.000

1.799
n=580

.773

9.773

.044
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Table 12 continued
Items

Options

Receiving the HPV vaccination is
too painful.

SD
D
NANDA
A
SA

Receiving the HPV vaccination is
expensive.

Receiving the HPV vaccination can
cause reactions.

I cannot remember to schedule the
HPV vaccination.

I am afraid to receive the HPV
vaccination because I don‟t think
HPV vaccine is effective.

I am afraid to receive the HPV
vaccination because I don‟t think
HPV vaccine is safe.

SD
D
NANDA
A
SA
SD
D
NANDA
A
SA
SD
D
NANDA
A
SA
SD
D
NANDA
A
SA
SD
D
NANDA
A
SA

Intend
(Expected
frequency)
45 (47)
78 (67)
52 (62)
20 (20)
7 (7)
24 (28)
37 (36)
79 (86)
47 (43)
15 (9)
12 (9)
25 (16) *
81 (69)
74 (77)
10 (31)
31 (40)
59 (72)
48 (51)
55 (33) *
9 (6) *
50 (28) *
80 (60) *
52 (63)
17 (37)
3 (14)
52 (27) *
72 (55) *
57 (56)
20 (40)
1 (24)

Not Intend
(Expected
frequency)
89 (87)
114 (125)
126 (116)
37 (37)
12 (12)
56 (52)
67 (68)
167(160)
77 (81)
11 (17)
14 (17)
22 (31)
116 (128)
147 (144)
79 (58) *
85 (76) *
149 (136) *
98 (95)
39 (61)
7 (10)
31 (53)
92 (112)
127 (117)
90 (70) *
38 (27) *
27 (52)
86 (103)
103 (104)
95 (75) *
67 (44) *

Value
(χ2)

p

n=580

5.442
n=580

.245

8.151
n=580

.086

33.884
n=580

.000

33.891
n=580

.000

69.382
n=580

.000

90.252

.000
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Table 12 continued
Items

Options

I do not know if I already had the
HPV vaccination

SD
D
NANDA
A
SA

Intend
(Expected
frequency)
66 (85)
51 (60)
25 (20)
44 (27) *
16 (10) *

Not Intend
(Expected
frequency)
179 (160) *
121 (112)
33 (38)
33 (50)
12 (18)

Value
(χ2)

p

n=580

33.534 .000
SD: Strongly Disagree; D: Disagree; NANDA: Neither Agree Nor Disagree; A: Agree; SA:
Strongly Agree
Statistical significance of Chi Square of Independence test is based on p value of .05
*: has both statistical (differences between the observed and expected frequencies for those who
intend/not intend for the same row based on z-score) and practical significance (applicable
meaning).

Research question 5. Is there any relationship between their intentions to receive the HPV
vaccination and participants‟ cues to action?
Null Hypothesis: There is no relationship between their intentions to receive the HPV
vaccination and participants‟ cues to action.
Hypothesis: Participants who have more cues to action have more intention to receive the
HPV vaccination.
Independent variable: participants‟ perceived cues to action (SA----SD).
Dependent variable: participants‟ intentions to receive HPV vaccine (Yes/No)
Chi-Square Test for Independence was used to determine whether or not participants‟ cues to
action related to their intention to receive the HPV vaccination (Table 13). Significant
relationships were found between participants‟ intention to receive the HPV vaccination and
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participants‟ agreement levels with the following 5 out of 10 statements that reflected
participants‟ cues to action: I have a stable relationship (χ2 (4, n=580) =14.605, p = .006 < .05), I
make sure a condom is used each time someone has anal, oral, or vaginal sex with me (χ2 (4,
n=580) =11.593, p = .021 < .05), My friends have suggested I get the HPV vaccine (χ2 (4, n=580)
=27.239, p = .000 < .05), My doctor has suggested I get the HPV vaccine, and My parents have
suggested I get the HPV vaccine (χ2 (4, n=580) =15.825, p = .003 < .05). Participants who had an
intention to receive the HPV vaccination agreed more and disagreed less to these five statements
which represent cues to action to receive the HPV vaccine. However, participants‟ responses to
the statements: I have visited a gynecologist (χ2 (4, n=580) =9.110, p = .058 > .05), I am
currently employed (χ2 (4, n=580) =7.78, p = .100 > .05), I frequently do things to improve my
health (χ2 (4, n=580) =6.739, p = .150 > .05), I received HPV related information (χ2 (4, n=580)
=5.627, p = .229 > .05), and I received HPV vaccination related information (χ2 (4, n=580)
=8.468, p = .076 > .05) had no relationship with their intention to receive the HPV vaccination.
The null hypothesis was rejected because participants‟ intentions to receive the HPV vaccination
and participants‟ cues to action were related for several statements. However, not all cues to
action measured in this study are related to a participants‟ intention to receive the HPV vaccine.
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Table 13
Relationship Between Intention to and Cues to Action for Receiving the HPV Vaccine
Items

Options

I have a stable relationship.

SD
D
NANDA
A
SA

I have visited a gynecologist.

I am currently employed.

I make sure a condom is used each
time someone has anal, oral or vaginal
sex with me.

I frequently do things to improve my
health.

SD
D
NANDA
A
SA
SD
D
NANDA
A
SA
SD
D
NANDA
A
SA
SD
D
NANDA
A
SA

Intend
(Expected
frequency)
25 (29)
32 (30)
35 (27)
45 (35)
65 (82)
33 (40)
64 (53)
10 (7)
37 (35)
58 (67)
13 (14)
32 (30)
8 (8)
72 (59)
77 (91)
9 (18)
59 (58)
51 (55)
43 (33) *
40 (38)
1 (2)
12 (15)
45 (43)
107 (95)
37 (46)

Not Intend
(Expected
frequency)
57 (53)
54 (56)
42 (50)
55 (65)
170 (153) *
80 (74)
87 (98)
11 (14)
64 (66)
136 (126)
26 (25)
54 (56)
16 (16)
98 (111)
184 (170)
42 (33) *
106 (107)
108 (104)
53 (63)
69 (71)
4 (3)
32 (29)
79 (81)
167 (179)
96 (87)

Value
(χ2)

p

n=580

14.605 .006
n=580

9.110
n=580

.058

7.78
n=580

.100

11.593 .021
n=580

6.739

.150
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Table 13 continued
Items

Options

I received HPV related information.

SD
D
NANDA
A
SA

I received HPV vaccination related
information.

My friends have suggested I get the
HPV vaccine.

My doctor has suggested I get the
HPV vaccine.

My parents have suggested I get the
HPV vaccine.

SD
D
NANDA
A
SA
SD
D
NANDA
A
SA
SD
D
NANDA
A
SA
SD
D
NANDA
A
SA

Intend
(Expected
frequency)
14 (20)
50 (53)
28 (22)
80 (76)
30 (31)
15 (22)
60 (56)
32 (24)
69 (70)
26 (30)
53 (76)
87 (83)
34 (25)
25 (15) *
3 (2)
27 (41)
42 (48)
34 (32)
66 (52) *
33 (29)
37 (76)
65 (68)
59 (36)
25 (15) *
16 (8) *

Not Intend
(Expected
frequency)
43 (37)
102 (99)
36 (42)
137 (141)
60 (59)
48 (41)
102 (106)
37 (45)
132 (131)
59 (55)

Value
(χ2)

p

n=580

5.627
n=580

.229

8.468

.076

166 (143) *
153 (156)
39 (48)
18 (28)
2 (3)
91 (77) *
96 (90)
59 (61)
82 (97)
50 (54)
181 (142) *
130 (127)
43 (66)
18 (28)
6 (14)

27.239 .000
n=580

15.825 .003
n=580

78.833 .000
SD: Strongly Disagree; D: Disagree; NANDA: Neither Agree Nor Disagree; A: Agree; SA:
Strongly Agree
Statistical significance of Chi Square of Independence test is based on p value of .05
*: has both statistical (differences between the observed and expected frequencies for those who
intend/not intend for the same row based on z-score) and practical significance (applicable
meaning).
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Research question 6. Is there any relationship between their intentions to receive the
HPV vaccination and participants‟ self-efficacy?
Null Hypothesis: There is no relationship between their intentions to receive the HPV
vaccination and participants‟ perceived self-efficacy.
Hypothesis: Participants who have more self-efficacy have more intention to receive the
HPV vaccination.
Independent variable: participants‟ self-efficacy (SA----SD).
Dependent variable: participants‟ intentions to receive HPV vaccine (Yes/No)
Chi-Square Test for Independence was used to determine whether or not participants‟
self-efficacy related to their intention to receive the HPV vaccination (Table 14). There was no
significant relationship found in the following 10 out of 12 statements that reflected participants‟
self-efficacy: I can arrange transportation to receive the HPV vaccination (χ2 (4, n=580) =4.825,
p = .306 > .05), I can arrange other things in my life to receive the HPV vaccination (χ2 (4,
n=580) =2.359, p = .670 > .05), I can talk to a professional about my concerns (χ2 (4, n=580)
=2.702, p = .609 > .05), I can find a way to pay for the HPV vaccination (χ2 (4, n=580) =3.126, p
= .537 > .05), I can make an appointment for the HPV vaccination (χ2 (4, n=580) =5.813, p
= .214 > .05), I know for sure I can get the HPV vaccination if I really want to (χ2 (4, n=580)
=3.555, p = .470 > .05), I know how to go about getting the HPV vaccination (χ2 (4, n=580)
=6.259, p = .181 > .05), I can find a place to get the HPV vaccination (χ2 (4, n=580) =7.375, p
= .117 > .05), I can get the HPV vaccine even if I did not get all of it when I was younger (χ2 (4,
n=580) =3.941, p = .414 > .05), and I can get the HPV vaccine if I am 26 years old or under (χ2
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(4, n=580) =8.867, p = .065 > .05). The null hypothesis was accepted based on a majority of the
statements not being related (p > .05). Participants‟ intentions to receive the HPV vaccination
and participants‟ self-efficacy were not significantly related. However, participants‟ responses on
the statement: I can receive the HPV vaccination even if I am worried (χ2 (4, n=580) =34.852, p
= .000 < .05), and I can receive the HPV vaccination even if I don’t know what to expect (χ2 (4,
n=580) = 23.800, p = .000 < .05) were related to their intention to receive the HPV vaccination.
Participants who had an intention to receive the HPV vaccination agreed more and disagreed less
to these two statements which represent self-efficacy of getting the HPV vaccination.
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Table 14
Relationship Between Intention to and Self-Efficacy of Receiving the HPV Vaccine
Items

Options

I can arrange transportation to receive
the HPV vaccination.

SD
D
NANDA
A
SA

I can arrange other things in my life to
receive the HPV vaccination.

I can talk to a professional about my
concerns.

I can receive the HPV vaccination
even if I am worried.

I can receive the HPV vaccination
even if I don‟t know what to expect.

SD
D
NANDA
A
SA
SD
D
NANDA
A
SA
SD
D
NANDA
A
SA
SD
D
NANDA
A
SA

Intend
(Expected
frequency)
6 (8)
13 (9)
11 (15)
102 (100)
70 (69)
4 (7)
11 (11)
23 (25)
102 (98)
62 (61)
6 (4)
11 (10)
24 (22)
103 (107)
58 (60)
2 (9)
5 (11)
13 (29)
123 (103) *
59 (50) *
4 (12)
15 (21)
19 (31)
111 (93) *
53 (46)

Not Intend
(Expected
frequency)
17 (15)
14 (18)
33 (29)
186 (188)
128 (129)
16 (13)
21 (21)
48 (46)
181 (184)
112 (113)
5 (7)
17 (18)
39 (41)
203 (199)
114 (112)
23 (16) *
27 (21) *
70 (54)
173 (193)
85 (94)
29 (21) *
45 (39)
69 (57)
157 (175)
78 (85)

Value
(χ2)

p

n=580

4.825
n=580

.306

2.359
n=580

.670

2.702
n=580

.609

34.852 .000
n=580

23.800 .000
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Table 14 continued
Items

Options

I can find a way to pay for the HPV
vaccination.

SD
D
NANDA
A
SA

I can make an appointment for the
HPV vaccination.

I know for sure I can get the HPV
vaccination if I really want to.

I know how to go about getting the
HPV vaccination.

I can find a place to get the HPV
vaccination.

I can get the HPV vaccine even if I
did not get all of it when I was
younger.

SD
D
NANDA
A
SA
SD
D
NANDA
A
SA
SD
D
NANDA
A
SA
SD
D
NANDA
A
SA
SD
D
NANDA
A
SA

Intend
(Expected
frequency)
9 (11)
19 (19)
42 (38)
97 (93)
35 (41)
1 (3)
7 (8)
22 (28)
121 (113)
51 (50)
2 (4)
12 (8)
20 (19)
106 (107)
62 (64)
17 (11)
41 (41)
25 (22)
74 (79)
45 (49)
4 (4)
20 (16)
33 (25)
94 (104)
51 (53)
2 (3)
4 (5)
64 (72)
94 (88)
38 (33)

Not Intend
(Expected
frequency)
24 (22)
36 (36)
66 (70)
170 (174)
82 (76)
9 (7)
16 (15)
58 (52)
202 (210)
93 (94)
8 (6)
12 (16)
35 (36)
202 (201)
121 (119)
15 (21)
78 (78)
38 (41)
152 (147)
95 (91)
8 (8)
25 (29)
39 (47)
206 (196)
100 (98)
7 (6)
10 (9)
144 (136)
159 (165)
58 (63)

Value
(χ2)

p

n=580

3.126
n=580

.537

5.813
n=580

.214

3.555
n=580

.470

6.259
n=580

.181

7.375
n=580

.117

3.941

.414
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Table 14 continued
Items

Options

I can get the HPV vaccine if I am 26
years old or under.

SD
D
NANDA
A
SA

Intend
(Expected
frequency)
0 (2)
9 (5)
56 (64)
103 (99)
34 (32)

Not Intend
(Expected
frequency)
5 (3)
6 (10)
128 (120)
181 (185)
58 (60)

Value
(χ2)

p

n=580

8.867 .065
SD: Strongly Disagree; D: Disagree; NANDA: Neither Agree Nor Disagree; A: Agree; SA:
Strongly Agree
Statistical significance of Chi Square of Independence test is based on p value of .05
*: has both statistical (differences between the observed and expected frequencies for those
who intend/not intend for the same row based on z-score) and practical significance
(applicable meaning).

Research question 7. Is there any relationship between their intentions to receive the HPV
vaccination and participants‟ race?
Null Hypothesis: There is no relationship between their intentions to receive the HPV
vaccination and participants‟ race.
Hypothesis: Participants who are White have more intention to receive the HPV vaccination.
Independent variable: race (White/Black/Asian-American/Native-American/Hispanic).
Dependent variable: participants‟ intentions to receive HPV vaccine (Yes/No)
Chi-Square Test for Independence was used to determine whether or not participants‟ race
related to their intention to receive the HPV vaccination (Table 15). There was a significant
relationship between participants‟ intentions to receive the HPV vaccination and race, χ2(4,
n=580) = 18.023, p=.001 < .05, so the null hypothesis was rejected. Participants‟ intentions to
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receive the HPV vaccination and participants‟ race were related. Participants who are White
(31.4%) had less intention to receive the HPV vaccination than Black (43.8%) and Asian (76.9%)
participants. Participants who are Asian have more intention to receive the HPV vaccination
(76.9%) than Black and White.

Table 15
Relationship Between Intention to Receive the HPV Vaccine and Participants’ Race

Race

White
Black
Asian-American
Native-American
Hispanic

Total

Intend to get vaccine
Yes
No
147 (31.4%)
321
35 (43.8%)
45
10 (76.9%)
1
(50%)
9 (52.9%)
202

3
1
8
378

Total
468
80
13
2
17
580

Pearson Chi-Square
Value (χ2)
18.023
Asymp. Sig. (2-sided)
.001
SD: Strongly Disagree; D: Disagree; NANDA: Neither Agree Nor Disagree; A: Agree; SA:
Strongly Agree
Statistical significance of Chi Square of Independence test is based on p value of .05
Research question 8. Is there any relationship between their intentions to receive the HPV
vaccination and participants‟ grade point average?
Null Hypothesis: There is no relationship between their intention to receive the HPV
vaccination and participants‟ grade point average.
Hypothesis: Participants who have higher grade point average have more intention to receive
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the HPV vaccination.
Independent variable: participants‟ GPA (4.0–3.5, 3.49–3, 2.99–2.5, under 2.5).
Dependent variable: participants‟ intentions to receive HPV vaccine (Yes/No)
Chi-Square Test for Independence was used to determine whether or not participants‟ GPA
related to their intention to receive the HPV vaccination (Table 16). No relationship was found
between GPA and intention to receive the HPV vaccine, χ2 (2, n=580) =1.815, p=0.403 > .05, so
the null hypothesis was accepted. Participants‟ intentions to receive the HPV vaccination and
participants‟ GPA were not significantly related.

Table 16
Relationship Between Intention to Receive the HPV Vaccine and Participants’ GPA

GPA

Total

3.0-4.0
2.0-2.99
Less than 2.0

Intend to get vaccine
Yes
No
171
328
31
48
0
2
202
378

Total
499
79
2
580

Pearson Chi-Square
Value (χ2)
1.815
Asymp. Sig. (2-sided)
.403
Statistical significance of Chi Square of Independence test is based on p value of .05
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Chapter V: Discussion

Major Findings
Participants‟ intention to receive HPV vaccination was significantly related to 4 out of 6
Health Belief Model constructs including participants‟ perceived susceptibility, perceived
severity, perceived benefits and perceived barriers. Participants‟ cues to action showed some
relationship with participants‟ intention to receive the HPV vaccine. However, there was no
relationship found between participants‟ self-efficacy and their intention to receive the HPV
vaccine. The findings of this research study found similar outcomes to other studies using the
constructs of HBM on HPV vaccination. Donadiki et al. (2014) found that perceived barriers and
perceived benefits were related to vaccination rates for college students. The findings of Reiter
(2009), that parental beliefs including cues to action (a doctor's recommendation to get the HPV
vaccine), perceived susceptibility and perceived barriers to receiving the HPV vaccine were
significantly correlated with HPV vaccination initiation.
Descriptive data showed that a majority of participants did not perceive themselves to be
susceptible to getting HPV. Participants had high perceived severity in regards to both genital
warts and cervical cancer, meaning they perceived these to be severe diseases. Participants also
had high self-efficacy for getting the HPV vaccine in addition to high perceived benefits and low
perceived barriers. Participants did identify several cues to action that were significantly related
to their intention to get the HPV vaccine. According to the literature on HBM and vaccines,

USE OF HEALTH BELIEF MODEL TO UNDERSTAND HPV VACCINE BEHAVIOR IN FEMALE UNDERGRADUATES

70

people will intend to get a vaccine if they have high perceived susceptibility, high perceived
severity, high perceived benefits, low perceived barriers, cues to action, and high self-efficacy. In
this study, participants had low perceived susceptibility but otherwise should have high intention
rates for getting the HPV vaccine. However, one in three participants in this study did not intend
to get the HPV vaccine.

Perceived Susceptibility
Participants‟ intentions to receive the HPV vaccination and participants‟ perceived
susceptibility of getting infected by HPV were related. Looking at the descriptive statistics, it
does not appear that participants had a high level of perceived susceptibility for getting infected
with HPV. However, when the participants‟ intention to get the HPV vaccine was looked at
specifically, perceived susceptibility did play a role in their intent to get the HPV vaccine.
Participants who had an intention to receive the HPV vaccination believed that they were likely
to get HPV when compared with those participants who did not intend to receive the HPV
vaccination. This conclusion showed similarity to former research on HPV vaccination behavior
of young adult women (Manhart et al., 2011); people perceiving they had low susceptibility to
infection had less intention to vaccinate. Also, Brewer and Fazekas (2007) recommended that
health professionals need to do a better job educating adolescents and young adults about the
high possibility of HPV infection.
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Perceived Severity
Participants who had an intention to receive the HPV vaccination agreed with the statements
that the thought of genital warts or cervical cancer scared them, made them feel nauseous, and
made their heart beat faster when compared with those who did not intend to receive the HPV
vaccination. This was consistent with the research of Lee et al. (2014) who demonstrated that
perceiving cancer as a terrifying disease is the primary reason people chose to get the HPV
vaccination. Participants who intend to receive the HPV vaccination agreed that genital warts or
cervical cancer would endanger their academics or career and their love relationships.
Participants who intend to receive the HPV vaccination agreed that cervical cancer would affect
their feelings about themselves, that their whole life would change, and that the problems from
cervical cancer would last a long time. Participants who intend to receive the HPV vaccination
agreed that cervical cancer is a hopeless disease that they are afraid to even think about cervical
cancer, and that cervical cancer would endanger their financial security. The concern, however, is
that one in three could not either agree or disagree with the statement: Cervical Cancer is a
hopeless disease. Is that because they did not know the fact that cervical cancer has a high
survival rate or some other reason?

Perceived Benefits
Participants‟ opinions towards perceived benefits were clearly separate between participants
who reported having intentions to take vaccination in the future and those who reported no
intention to receive the HPV vaccine. Participants who intended to get the HPV vaccine agreed
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that getting the HPV vaccine would decrease their worry about cervical cancer, that treatment
would not be as bad, that it would be the best way to both prevent HPV and cervical cancer, and
decrease their chances of dying from cervical cancer. Participants who intend to get the HPV
vaccine agreed that vaccines would help them to prevent diseases, too. Three out of four (78.7%)
participants agreed with the benefits of vaccination but only about half of the participants agreed
with those statements about the benefits of HPV vaccination. About 40 percent of participants
disagreed or didn‟t know that If I receive the HPV vaccine I would not worry as much about
cervical cancer. About 50 percent of participants disagreed or didn‟t know that If I receive the
HPV vaccine, my treatment for HPV may not be as bad. There were 45 percent of participants
who disagreed or don‟t know that Having the HPV vaccination is the best way for me to prevent
HPV and cervical cancer. There is still a gap that exists between participants‟ belief in the
benefits of general vaccination and the benefits of HPV vaccination.

Perceived Barriers
Participants who believe the HPV vaccination causes reactions do not think the HPV vaccine
is effective or do not think the HPV vaccine to be safe have less intention of getting the HPV
vaccine. Effectiveness of the vaccine was identified as a barrier significantly related to
participants‟ HPV vaccination intention in this research which is similar with the findings of
Manhart et al. (2011) and Brewer and Fazekas (2007). Belief that the vaccine is less than 75%
effective was considered as a significant barrier for choosing to be vaccinated among young
adult women (Manhart et al., 2011). Brewer and Fazekas (2007) reviewed 27 studies about HPV
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and HPV vaccination and recommended that the United States should highlight high vaccine
efficiency. The three dose procedure which was identified as a barrier by Niccolai, Mehta, and
Hadler (2011) did not have a significant relationship with female undergraduate students‟
intention to receive HPV vaccination in this study as only 12.1% of participants considered the
three dose procedure as a barrier.

Cues to Action
Participants who intend to get the HPV vaccine were in stable relationships, use condoms
consistently, and have a friend, parent, or doctor who has suggested they get the HPV vaccine.
This study‟s conclusion demonstrated the same findings as other research regarding peer
influence as an important factor contributing to people choosing to get the HPV vaccination
(Cohen & Head, 2013) and the recommendation by Brewer and Fazekas (2007) who pointed out
that doctor‟s recommendations to get the HPV vaccine should be encouraged. However, this
research study had different findings in regards to cues to action when compared with Donadiki
et al. (2014). Donadiki found that being employed, visiting physicians, and having healthy
behaviors were related to HPV vaccination intention but these cues to action were not related to
vaccination intention in this study. Friedman and Shepeard‟s (2007) finding about providing
people with information about HPV and HPV vaccination related to the intentions to receive
HPV vaccination were not supported by the findings of this research study.
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Self-Efficacy
The results showed that most participants had high self-efficacy for getting the HPV vaccine
for all barriers presented in the HPV Vaccination Belief Survey. However, not all of the
self-efficacy items were found to be significantly related to HPV vaccination intention. The only
self-efficacy statements that had a significant relationship with HPV vaccination intention were
the belief that respondents could receive the HPV vaccination even though they may be worried
or they do not know what to expect from getting the HPV vaccine.

Race and Grade Point Average
The results showed that participants‟ race was significantly related to their intention to
receive the HPV vaccine. Participants who were White had the least intention to receive the HPV
vaccination compared to other races. Participants who identified as Asian had more intention to
receive the HPV vaccination. Also, among those who received the HPV vaccine,
Native-Americans had the highest rate to finish all three doses (100%). Whites (73.59%) had a
lower rate than Hispanics (80.95%) and Asians (75.86%), but had a higher rate than Blacks
(65.63%) to finish all three doses. The finding are different from research of Niccolai et al. (2011)
that found, among female patients age 21 years or younger, Caucasians to be more likely to
finish all three doses of HPV vaccination than African Americans or Hispanics. Hispanics were
significantly less likely to complete the series than African Americans (Neubrand et al., 2009).
Participants‟ intentions to receive the HPV vaccination and their GPA were not significantly
related.
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Limitations
1. This was a cross-sectional survey, causality cannot be inferred.
2. The survey was based on self-reported information. Facticity wasn‟t guaranteed and personal
perceptions could have been overestimated.
3. The survey was filled out by students who volunteered to participate in the study. So the
result of the study cannot represent the opinions of people who refused to participate in the
study.
4. In the demographic question of HPV Vaccination Belief Survey, 21 years old was included in
both the age group options. This makes it impossible to determine which group 21-year-olds
chose but since age was not included in any of the research hypotheses, the study was not
affected.
5. GPA can only represent academic performance. GPA cannot represent participants‟
knowledge level about HPV vaccination. Knowledge level about HPV was identified as an
important role that influenced people‟s decision on HPV vaccination. There was no efficient
method to test knowledge level in this research study.
6. The agreement questions were not the best way to ask about perceived susceptibility. It
should be asked as “How likely are you to be infected by HPV?”
7. There were 5 questions including two diseases, “genital warts or cervical cancer.” These
are double barreled questions which could have affected the responses to this question. It is
impossible to determine if respondents were answering the question in response to genital
warts or cervical cancer.
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8. About 300 participants did not finish the entire survey. Although they completed the majority
of the survey, the question about their vaccination status and intention to get the HPV
vaccine was at the end of the survey in the demographic section which they did not complete.
Since all of my research questions included intention to get the HPV vaccine, the unfinished
surveys could not be included in the study.

Delimitations
The sample being used requires that the researcher have delimitations that may reduce the
external validity of the study. The delimitations of the study include the following:
1. This study was restricted to subjects identified as female undergraduate students. The students
had a higher education and more knowledge than females in the general population. As a
result, the data cannot represent the general female population.
2. This study was restricted to participants recruited at Eastern Michigan University. Eastern
Michigan University is a public university. Students‟ knowledge levels and attitudes about a
disease may be different from other universities such as private universities or universities in
other States. So the research result cannot represent all undergraduates in the United States.
3. Questions in the survey were all closed questions. Participants could not express opinions
other than the concepts included in the survey. If key items were missing this would be a
threat to the internal validity of the results.
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Recommendations for Future Research
1. Health Belief Model is a very good method to analyze people‟s health behavior on
vaccination. A tested HBM instrument should be set up for vaccination so that the HBM
instrument can be used in analyzing multiple kinds of vaccination.
2. There are conflicting findings between this research study and other studies in regards to race
and HPV vaccination (Neubrand et al., 2009; Niccolai et al., 2011). Future research should
include race as a factor in HPV vaccination rates and intention to determine if a difference
exists between races and ethnicities in regards to HPV vaccination.
3. The survey instrument for this study was based on validated instruments used for other
studies. However, before using this survey instrument in future studies, tests for validity and
reliability should be done.

Recommendations for Health Education Professionals
1. While the majority of female undergraduate students reported that they had received
information about HPV and HPV vaccination, this did not relate to vaccination intention.
However, recommendations from friends, doctors, and parents made a significant difference
in people‟s intention to receive HPV vaccination. Health educators should encourage doctors,
people who received the HPV vaccine, and parents who support the HPV vaccine to
recommend and advocate HPV vaccination to their patients, friends, and family members.
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2. This study indicated that people who use condoms had significantly higher intention to get
the HPV vaccine. However, the majority of participants did not use a condom each time they
had sex. So health educators should advocate more about the benefits of condom use on
college female students. Along with the health education of using condoms to avoid
pregnancy and prevent STDs, HPV and HPV vaccine related information can be included.
The educational material should include information that condom use may reduce the risk of
HPV but not eliminate the risk because HPV can be transmitted by skin-to-skin contact.
3. About one in five participants do not know if they already had the HPV vaccination.
Knowing one‟s own vaccination history is important and should be addressed by health
educators. Additionally, although people can assess their medical records from their doctors,
more convenient internet-based information systems about people‟s vaccination trail should
be set up. When children grow up, they should be able to easily check their vaccination
record using their mobile app or computer.
4. About one third of participants didn‟t know or believe HPV vaccination to be effective and
safe. About one third (33.5%) of participants do not know if the HPV vaccine can cause
reactions and this lack of education is significantly related to people‟s intention to receive
HPV vaccination. However, this does not seem to be a lack of information availability since
the majority of people reported they had received HPV and HPV vaccine information. So
HPV vaccination related information should be changed in advocacy materials. Health
educators should provide more information about the side effects, safety, and effectiveness of
HPV vaccinations. These must be highlighted points in HPV-related information distribution.
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5. About one third (32.4%) of participants do not know if HPV vaccination is expensive. The
information might be missing in former advocacy of the HPV vaccine. Cost is always an
important piece of information for any vaccination. HPV vaccine cost is covered by multiple
medical insurances. Beside insurance, the vaccine manufacturers also provide free HPV
vaccination programs to people who cannot afford HPV vaccination. GlaxoSmithKline offers
the Vaccines Access Program including free Cervarix to women without insurance, who are
low income, or too old for the Medicaid Vaccines for Children Program. The Merck Vaccine
Patient Assistance Program provides free Gardasil to people older than 19 without insurance
or who cannot afford the vaccine (National Cancer Institute, 2015). Information for the cost
of HPV vaccination must be a highlighted point in distributed HPV related information.
6. Perceived susceptibility did play a role in participants‟ intention to get the HPV vaccine.
However, the overall agreements of perceived susceptibility were very low. There may be
reasons why these particular participants did not perceive themselves to be susceptible (in
stable relationship, not sexually active) but we know from statistics about HPV that college
age women do have high susceptibility. Health educators should be doing more to increase
awareness regarding the susceptibility of undergraduate students getting infected with HPV.
7. Health educators who work in university/college student health centers should consider
conducting educational outreach efforts about HPV vaccination for female students ages
18–26.
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Appendix A:
HPV Vaccination Belief Survey
Directions: Please complete each of the following items according to the instructions. Your
responses will be confidential. Thank you for your professional courtesy.
Perceived Susceptibility
Strongly Agree Neither Disagree Strongly
Agree
(4)
Agree
(2)
Disagree
(5)
nor
(1)
Disagree
(3)
1 It is likely that I will get HPV.
2 My chances of getting HPV in the
next few years are great.
3 I feel I will get HPV sometime
during my life.
Perceived Severity
Strongly Agree Neither Disagree Strongly
Agree
(4)
Agree
(2)
Disagree
(5)
nor
(1)
Disagree
(3)
4 The thought of genital warts or
cervical cancer scares me.
5 When I think about genital warts
or cervical cancer I feel nauseous.
6 If I had genital warts or cervical
cancer my academics and career
would be endangered.
7 When I think about genital warts
or cervical cancer my heart beats
faster.
8 Genital warts or cervical cancer
would endanger my love
relationships.
9 Cervical cancer is a hopeless
disease.
10 My feelings about myself would
change if I got cervical cancer.
11 I am afraid to even think about
cervical cancer.
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12 My financial security would be
endangered if I got cervical cancer.
13 Problems I would experience from
cervical cancer would last a long
time.
14 If I got cervical cancer, it would be
more serious than other diseases.
15 If I had cervical cancer, my whole
life would change.
Perceived Benefits
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Strongly
Agree
(5)

Agree
(4)

Neither
Agree
nor
Disagree
(3)

Disagree
(2)

Strongly
Disagree
(1)

Strongly
Agree
(5)

Agree
(4)

Neither
Agree nor
Disagree
(3)

Disagree
(2)

Strongly
Disagree
(1)

16 If I receive the HPV vaccine, I
would not worry as much about
cervical cancer.
17 Receiving vaccinations will help
me prevent diseases.
18 If I receive the HPV vaccine, my
treatment for HPV may not be as
bad.
19 Having the HPV vaccination is the
best way for me to prevent HPV
and cervical cancer.
20 Having the HPV vaccination will
decrease my chances of dying
from cervical cancer.
Perceived Barriers

21 I am afraid to receive the HPV
vaccination because I might find
out I‟m carrying HPV already.
22 I am afraid to receive the HPV
vaccination because I don‟t
understand the three-dose
procedure.
23 I don‟t know how to go about
receiving the HPV vaccination.
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24 Receiving the HPV vaccination is
too embarrassing because it is STD
related.
25 Receiving the HPV vaccination
takes too much time.
26 Receiving the HPV vaccination is
too painful.
27 Receiving the HPV vaccination is
expensive.
28 Receiving the HPV vaccination
can cause reactions.
29 I cannot remember to schedule the
HPV vaccination.
30 I am afraid to receive the HPV
vaccination because I don‟t think
HPV vaccine is effective.
31 I am afraid to receive the HPV
vaccination because I don‟t think
HPV vaccine is safe.
32 I do not know if I already had the
HPV vaccination
Cues to Action

33
34
35
36

37
38
39
40

I have a stable relationship.
I have visited a gynecologist.
I am currently employed.
I make sure a condom is used each
time someone has anal, oral or
vaginal sex with me.
I frequently do things to improve
my health.
I received HPV related
information.
I received HPV vaccination related
information.
My friends have suggested I get
the HPV vaccine.

Strongly
Agree
(5)

Agree
(4)

Neither
Agree
nor
Disagree
(3)

Disagree
(2)
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Strongly
Disagree
(1)
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41 My doctor has suggested I get the
HPV vaccine.
42 My parents have suggested I get
the HPV vaccine.
Self-Efficacy

43 I can arrange transportation to
receive the HPV vaccination.
44 I can arrange other things in my
life to receive the HPV
vaccination.
45 I can talk to a professional about
my concerns.
46 I can receive the HPV vaccination
even if I am worried.
47 I can receive the HPV vaccination
even if I don‟t know what to
expect.
48 I can find a way to pay for the
HPV vaccination.
49 I can make an appointment for the
HPV vaccination.
50 I know for sure I can get the HPV
vaccination if I really want to.
51 I know how to go about getting the
HPV vaccination.
52 I can find a place to get the HPV
vaccination.
53 I can get the HPV vaccine even if I
did not get all of it when I was
younger.
54 I can get the HPV vaccine if I am
26 years old or under.

Strongly
Agree
(5)

Agree
(4)

Neither
Agree
nor
Disagree
(3)

Disagree
(2)
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Strongly
Disagree
(1)
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Demographics
Are you a female undergraduate student?

Yes
No

Age

Less than18
18-21
21-26
26+

How do you describe or identify yourself

White
Black
Asian-American
Native-American
Hispanic

Grade point average (GPA)

3.0-4.0
2.0-2.99
Less than 2.0

Do you intend to get the HPV vaccine in the future?

Yes

(Check only 1 answer)

No
I already got the vaccine

Have you received the HPV vaccination before?

No
One dose
Two doses
All three doses
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Appendix B: Informed Consent Letter

Eastern Michigan University
School of Health Promotion and Human Performance
Information Sheet
This Informed Consent Form is for Eastern Michigan University (EMU) female
undergraduates who complete the Human Papillomavirus (HPV) vaccine related health belief
survey. The survey is for my thesis “Use of the Health Belief Model to Understand HPV Vaccine
Behavior in Female Undergraduates”.
Introduction
I am a graduate student studying in EMU Health Education masters program. This survey is
part of my master thesis. I am going to give you information and invite you to be part of this
research. You do not have to decide today whether or not you will participate in the research.
Before you decide, you can talk to anyone you feel comfortable with about the research. If you
have questions later, please feel free to ask me.
Purpose of the research
HPV is considered as the most common sexually transmitted infection (STI) causing
cervical cancer and other diseases. The purpose of this study is to use the Health Belief Model to
identify the main factors that relate to whether or not an Eastern Michigan University female
undergraduate intends to receive the HPV vaccine. This study will provide information for
further health-related interventions to increase the HPV vaccine rate.
Study procedures
This is an online survey. The first section of the online survey is an informed consent letter.
Informed consent is assumed when you press the next button at the end of the informed consent.
If you choose not to give your consent, you will be given directions to exit the instrument. Once
clicking on the next button, the questionnaire for this study will appear. The survey will take 20
minutes to complete. Once you are finished with the questionnaire you will be asked to click the
next button. Clicking on the next button at the end of the questionnaire will take you to the raffle
section.
Benefits and Risks
The risks of this study are minimal. You will be asked to fill out your opinions regarding
HPV, cervical cancer, and the HPV vaccine. You may experience some anxiety while completing
the survey as HPV is cancer and STD related. If, for any reason, you become uncomfortable with
this study, please feel free to notify the researchers.
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Costs and payments
If you complete the entire survey, you may choose to enter a raffle for one of three $100 gift
cards. Although your name and email address are required for the raffle, this information is
separate from the HPV survey to ensure confidentiality. The survey is not attached to your email
and once you click „next‟ to complete the survey, your survey is stored. A new file is then created
for the raffle. Your personal information for the raffle will be erased once the winners are drawn.
All winners will be notified by email.
Voluntary Participation
Your participation is strictly voluntary. You have the right to refuse participation and
withdraw from participation in the study at any time. You may refuse to answer any item on the
testing instrument. No penalties or negative consequences will result from your withdrawal or
refusal.
Confidentiality and Anonymity:
All information collected will be held in the strictest of confidence. No names will be placed
on the testing instruments at any time. Your name and/or email address will not be connected in
any way with your questionnaire. Be assured that your name will in no way be associated with
this study. Data will be saved as Excel files and SPSS files and stored in a locked cabinet in the
researcher‟s room. The final data of this research will be stored in a locked cabinet for five years
before being destroyed.
Results of the Study:
The results of this research study will be shared with the members of the principal
investigator‟s thesis committee members. In addition, the results may be presented in a
professional health education forum (conference presentations, posters, manuscripts).
You may print or write down this information for your reference. If you have any questions
or concerns related to this study, please contact:
Chu He
Master Student
734-218-6119
che1@emich.edu
Megan Sterling, Ph.D.
Faculty Supervisor
734-487-2829
Mrickar2@emich.edu
For information about your rights as a participant in research, you can contact the EMU Human
Subjects Review Committee at human.subjects@emich.edu or 734-487-3090.
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Eastern Michigan University
School of Health Promotion and Human Performance
Consent Form
Clicking the “I Consent” button below indicates that you have read and have had the
opportunity to ask questions and that you are satisfied with the answers you received and have
decided to voluntarily participate in the study. Again, if you have any questions, please feel free
to contact the researchers listed above before participating.
I will participate in this study which uses the Health Belief Model to identify the main
factors that relate to whether or not an Eastern Michigan University female undergraduate
intends to receive the HPV vaccine.
By participating in this study, I will be asked to fill out my opinions regarding HPV, cervical
cancer, and the HPV vaccine. While the risks of participation are minimal, I may experience
some anxiety while completing the questionnaire.
My participation is strictly voluntary. I have the opportunity to enter into a drawing for one
of three $100 gift cards. I have the right to refuse participation and withdraw from the study at
any time. I may refuse to answer any item on the testing instrument. No penalties or negative
consequences will result from my withdrawal or refusal to participate in the study.
All information collected will be held in the strictest of confidence and that no names will be
placed on the testing instruments at any time and that my name and/or email address will in no
way be associated with my questionnaire or this study.
I have read, and I have had the opportunity to ask questions and am satisfied with the
answers I have received.
“I Consent”
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Appendix C:
Raffle Entry Form
Direction: Please enter your name and email address below. You will be entered into a random
drawing to receive one of three $100 Amazon Gift cards
Name

Email Address
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Appendix D:Masteis Thesis Proposal Approval Form

96

USE OF HEALTH BELIEF MODEL TO UNDERSTAND HPV VACCINE BEHAVIOR IN FEMALE UNDERGRADUATES

97

Appendix E:
IRB Approval Letter

RESEARCH @ EMU
UHSRC Determination: EXEMPT
DATE: August 18, 2015
TO: Chu He
Eastern Michigan University
Re: UHSRC: # 782450-1
Category: Exempt category 2
Approval Date: August 18, 2015
Title: Use of the Health Belief Model to Understand HPV Vaccine Behavior in Female
Undergraduates
Your research project, entitled Use of the Health Belief Model to Understand HPV Vaccine Behavior
in Female Undergraduates, has been determined Exempt in accordance with federal regulation 45 CFR
46.102. UHSRC policy states that you, as the Principal Investigator, are responsible for protecting the
rights and welfare of your research subjects and conducting your research as described in your protocol.
Renewals: Exempt protocols do not need to be renewed. When the project is completed, please submit
the Human Subjects Study Completion Form (access through IRBNet on the UHSRC website).
Modifications: You may make minor changes (e.g., study staff changes, sample size changes, contact
information changes, etc.) without submitting for review. However, if you plan to make changes that
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alter study design or any study instruments, you must submit a Human Subjects Approval Request
Form and obtain approval prior to implementation. The form is available through IRBNet on the UHSRC
website.
Problems: All major deviations from the reviewed protocol, unanticipated problems, adverse events,
subject complaints, or other problems that may increase the risk to human subjects or change the
category of review must be reported to the UHSRC via an Event Report form, available through IRBNet
on the UHSRC website
Follow-up: If your Exempt project is not completed and closed after three years, the UHSRC office will
contact you regarding the status of the project.
Please use the UHSRC number listed above on any forms submitted that relate to this project, or on any
correspondence with the UHSRC office.
Good luck in your research. If we can be of further assistance, please contact us at 734-487-3090 or via
e-mail at human.subjects@emich.edu. Thank you for your cooperation.
Sincerely,
April Nelson, MS
Research Compliance Administrator
University Human Subjects Review Committee
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Appendix F: Email Survey Request Form
EASTERN MICHIGAN UNIVERSITY
Email Survey Distribution Request Form

Note: Requests associated with thesis or dissertation research must be submitted by the faculty
advisor on behalf of the student.
Name:

Chu He

Email:
Phone Number:

che1@emich.edu
734-218-6119

Requested Email Distribution Date:

September 14- September 22

(Please indicate when you would like the email sent. Dates should be flexible to allow for necessary
staggering and balancing of email survey requests being sent to EMU affiliates.)

Project Name:
Use of the Health Belief Model to Understand HPV Vaccine Behavior
in Female Undergraduates

(Enter the name of your research study)

Suggested Email Subject Line:

Master’s thesis research survey opportunity

(Enter a suggested email subject line. Subject lines should be short and descriptive)

"Reply To" Address for Email Request:

che1@emich.edu

(Indicate the address that should be utilized as the "reply to" address when sending your email
request)

Body of Email Request: First email script and the reminder email script are attached. Please
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attached the body of the email request.

Target Population:

EMU 18-26 year old female undergraduate students

Indicate who the email request should be sent to. If indicating a faculty and/or student population,
list any/all target sub-groups that should be targeted.

Number of Target Email Recipients:

About 10,000

(Indicate the total number of email requests that should be sent. Except in rare circumstances, you
should specify only the necessary number of survey requests needed for your study rather than requesting
distribution to the entire population at EMU.)

Purpose of the Research
Research project with intent to disseminate through publications (including thesis or
dissertation), conference presentations, web journals, etc.
☐ Internal research for program improvement purposes only. Please complete the attached Human
Subjects Research Determination form for review and determination by the Research
Compliance Officer.
Do you have IRB approval to conduct this survey?
X

Yes

X

If yes, please provide the IRB Approval No.

☐

No.
Please explain why IRB approval has not been obtained:
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Additional comments or information:
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Please indicate if you have additional requirements,

needs or expectations concerning this survey distribution request.
A follow up email on September 21st (one week after the first) will be sent as a reminder to please
fill out the survey sent in the first email).
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EASTERN MICHIGAN UNIVERSITY
Covered Human Subjects Research
Determination Form
Please complete the following form and attached a one-page description of your research project.
1. Research means a systematic investigation, including research development, testing and
evaluation, designed to develop or contribute to generalizable knowledge. Activities, which
meet this definition constitute research for purposes of this policy, whether or not they are
conducted or supported under a program which is considered research for other purposes. For
example, some demonstration and service programs may include research activities (45 CFR
46.102(d)).
a. Does this activity include a Systematic investigation that involves a prospective plan
incorporating data collection, either quantitative or qualitative, and data analysis to answer a
question?

☐

Yes

X

No

b. Does this activity include an investigations designed to develop or contribute to
generalizable knowledge, or designed to draw general conclusions, inform policy, or
generalize findings beyond a single individual or an internal program (e.g., publications or
presentations)?

X

Yes

☐

No

Note: Research results do not have to be published or presented to qualify the experiment or
data gathering as research. The intent to contribute to "generalizable (scholarly) knowledge"
makes an experiment or data collection research, regardless of publication. Research that never
is published is still research. Participants in research studies deserve protection whether or not
the research is published.
Examples of activities that typically are not generalizable include: biographies, oral histories that
are designed solely to create a record of specific historical events, service or course evaluations,
unless they can be generalized to other individuals, services, courses, or concepts where it is not
the intention to share the results beyond the EMU community, classroom exercises solely to
fulfill course requirements or to train students in the use of particular methods or devices,
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quality assurance activities designed to continuously improve the quality or performance of a
department or program where it is not the intention to share the results beyond the EMU
community.
Thesis or dissertation projects conducted to meet the requirement of a graduate degree are
usually considered generalizable, and require IRB review and approval.
2. Does this research involve collecting data from living individuals?

X

Yes

☐

No

Will the Investigator obtain:
a. Data through intervention or interaction with the individual?

☐

Yes

X

No

b. Identifiable private information?

☐

Yes

X

No

Certification Statement
If it is determined that IRB review and approval is not required for my research project because it is
does not meet the definition of research presented her, I agree that the results will not be used for
purposes of contributing to the generalizable knowledge, including the dissemination and
publication of these results.

Signature:

Chu He

Name:

Chu He

Email:
Phone Number:

che1@emich.edu
734-218-6119
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Appendix G:
Initial Email Script
Title: Master‟s thesis research survey opportunity

Greetings!

I am a graduate student studying in the EMU Health Education master‟s program. This
survey is part of my master‟s thesis. The purpose of this study is to identify the main factors that
relate to whether or not an Eastern Michigan University female undergraduate intends to receive
the HPV vaccine. HPV is considered as the most common sexually transmitted infection (STI)
causing cervical cancer and other diseases. I would appreciate it if you would complete my HPV
Vaccination Belief Survey, which should take about 20 minutes (or less) of your time.
You can complete my HPV Vaccination Belief Survey anytime between today, September 16
and Wednesday, September 30 at 11pm. Only completed surveys will be eligible to be entered
into a random drawing to receive one of three $100 Amazon gift cards. You will be asked to
leave your email address if you want to be entered into the raffle for gift cards. Data from the
raffle section will be separate from the HPV survey section to ensure confidentiality.
Follow this link to the Survey:
Take the Survey
Or copy and paste the URL below into your internet browser:
https://emuir.co1.qualtrics.com/SE?Q_DL=3TLpW3RlNNhq75z_1QPPzaexGzYBCex_ML
RP_6mbPxEX2aPYI3UV&Q_CHL=email
Thanks!

Chu
Health Education
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Appendix H:
Reminder Email Script
Title: Reminder for master‟s thesis research survey opportunity
Greetings!

I am a graduate student studying in the EMU Health Education master‟s program. I sent you
an email to invite you to attend a survey and raffle last week. If you have already completed my
HPV Vaccination Belief Survey thank you very much and please ignore this email. If you have
not completed the survey yet, you can complete my HPV Vaccination Belief Survey anytime
between today, September 23 and Wednesday, September 30 at 11pm. Only completed surveys
will be eligible to be entered into a random drawing to receive one of three $100 Amazon gift
cards. You will be asked to leave your email address if you want to be entered into the raffle for
gift cards. Data from the raffle section will be separate from the HPV survey section to ensure
confidentiality.
The purpose of this survey is to identify the main factors that relate to whether or not an
Eastern Michigan University female undergraduate intends to receive the HPV vaccine. HPV is
considered as the most common sexually transmitted infection (STI) causing cervical cancer and
other diseases.
Follow this link to the Survey:
Take the Survey
Or copy and paste the URL below into your internet browser:
https://emuir.co1.qualtrics.com/SE?Q_DL=3ld9OvTZLUshMOh_1QPPzaexGzYBCex_MLRP_
5iDMo9hSTbaxlkN&Q_CHL=email
Thanks!

Chu
Health Education

